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1. Introduction 
 
1.1 Chlamydiales 
Chlamydiales are obligate intracellular gram-negative bacteria that all share a unique 
developmental cycle. Their host range varies from animals (like mammals or insects) to 
protozoa. Different diseases are caused by Chlamydiae, still not a lot is known about this 
organism. Its obligate intracellular development is challenging for researchers and no 
techniques are available to easily manipulate Chlamydiae genetically, therefore our 
understanding of Chlamydiae biology is still very fragmented.  
 
1.1.1 The order Chlamydiales 
So far, the order Chlamydiales is the only one in the class Chlamydiae. This order seems to be 
phylogenetically separated from other eubacteria, having proteins that show only a low level 
of homology with known proteins (Subtil and Dautry-Varsat, 2004). The tree in figure 1 has 
been proposed by Horn (Horn, 2008). It has only recently been suggested to divide the family 
Chlamydiaceae into two genera, Chlamydia and Chlamydophila (former Chlamydia). Genetic 
studies support this new distinction as well as biochemical markers. Only bacteria of the 
genus Chlamydia (C. trachomatis, C. suis and C. muridarum) contain detectable amounts of 
glycogen particles, this has never been seen for Chlamydophila (Chiappino et al., 1995; 
Rogers et al., 1996). However, the proposal for a division of the genera has largely been 
critisized by the chlamydial community (Stephens et al., 2009). So far, both (the two genera 
of Chlamydophila and Chlamydia as well as Chlamydia as one genus comprising all the 
members) are common. In this work the two genera Chlamydia and Chlamydophila suggested 
also by Horn (Horn, 2008) will be applied.  
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Figure 1: Genetic structure of the phylum Chlamydiae. Calculated by 16S rRNA sequence data. Adapted from 
Horn (2008) 
 
1.1.2 Diseases and Hosts     
However, diseases and host range (table 1) do not seem to be linked to the different genera. 
The main human pathogens comprise C. trachomatis, C. pneumoniae and C. psittaci. C. 
trachomatis is a major cause of blindness and sexually transmitted diseases. Depending on its 
serovar it leads among others to trachoma, lymphogranuloma venereum and urethritis. A 
substantial proportion of the infection is asymptomatic (Stamm, 1999), but persistant 
infections can cause infertility or ectopic pregnancies. Chlamydiae can enter a non-infectious 
but viable state called persistence when exposed to stress. Chlamydiae undergoing the 
persistent state do not ressemble to normal forms of Chlamydiae. Their structure seems to be 
enlarged, irregular and less electron-dense. Although these so-called ABs (abberant bodies) 
have been demonstrated in vivo, it is still not determined whether Chlamydiae undergo a 
conversion to ABs in order to establish chronic host infections (Schoborg, 2011).  The most 
frequent illnesses linked to C. pneumoniae are pneumonia and bronchitis (with an overall 
share of 10 and 5%, respectively) (Kuo et al., 1995). Connections to artherosclerosis are under 
investigation. Even though the main host of C. psittaci are birds, it is also infective for 
humans and causes psittacosis, a life-threatening pulmonary infection (Gregory and Schaffner 
1997).  
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Parachlamydiaceae comprise intracellular symbionts of free-living amoebae, and are 
therefore often designated as environmental Chlamydiae (Hayashi et al., 2010; Leitsch et al., 
2010; Collingro et al., 2005). Interestingly, recent studies showed that a large number of 
sequences in the genomes of Parachlamydia acanthamoeba and Candidatus Protochlamydia 
amoebophila are related to genes in plants (Collingro et al., 2011).  
 
Table 1: Typical hosts of Chlamydiales species. 
 
1.1.3 Developmental cycle      
Despite their different host range, Parachlamydiaceae and Chlamydiaceae possess a common 
biphasic developmental cycle (figure 2). Infectious particles called elementary bodies (EBs) 
enter host cells by a to date still obscure mechanism. It has been suggested, that 
Chlamydiaceae (similar to Shigella and Salmonella) inject effector proteins into epithelial 
cells prior to invasion. This culminates in remodeling of the host’s actin cytoskeleton at the 
site of entry and finally leads to the pathogen’s uptake (Dunn and Valdivia, 2010). Once in 
the cytoplasm, they build up parasitophorous compartments called inclusions, where they 
develop and convert into metabolically active reticulate bodies (RBs). RBs are capable of 
vegetative growth and of division by binary fission. At the last step of their developmental 
cycle they reconvert into EBs and are released. Depending on the strain, this can take up to 72 
h (Fields and Hackstadt, 2000; Subtil et al., 2001). In most of the literature EBs are referred to 
as being metabolically inert and often compared to a spore-like stadium. However, it has been 
shown by Haider et al. (Haider et al., 2010) that EBs of Parachlamydia acanthamoeba and 
Chlamydia trachomatis are metabolically active for a restricted timespan after being released 
from their host cell implying the supply of appropriate nutrients.  
Chlamydiae do not only interfere with the host cell prior to or during their internalization, 
they also hijack the cytoskeleton during infection (Carabeo et al., 2002), cause alterations of 
the host cell’s signal-transduction pathways, repress apoptosis for the duration of the 
developmental cycle and finally induce cell death to release chlamydial progenies (Byrne and 
C. abortus C. psittaci C. felis C. caviae C. pecorum C. pneumoniae 
mammals birds cats guinea pig mammals humans 
Chlamydiales C. trachomatis C. suis C. muridarum P. acanthamboeba C. P. amoebophila 
Typical Host humans swine mice, hamsters acanthamoeba acanthamoeba 
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Ojcius, 2004). It has been shown that Chlamydiae possess a functional type III secretion 
system (TTSS) from very early stages on. Clifton et al. (Clifton et al., 2004) discovered the 
first early TTSS secreted protein, the translocated actin-recruiting phosphoprotein (Tarp). It 
has been suggested that the TTS machinery is already present and “preloaded” with Tarp on 
EBs in order to mediate engulfment of the pathogen upon contact with a host cell (Clifton et 
al., 2004). Secretion of proteins (effectors) can be targeted to the inclusion membrane as well 
as to the cytoplasm of the host cell. Unpublished data of Subtil (Institut Pasteur, Paris) 
suggest secretion of effectors into the inclusion lumen, but their function is still not clear. 
Identification of TTS effectors is not an easy task. Its attempt through direct functional 
analysis is strongly hampered by the genetical intractability of Chlamydiae. Interesting assays 
have been developed to overcome this problem, and two of them (a bioinformatical approach 
and a heterologous test of secretion) will be detailed below. 
 
1.2 Type III Secretion System 
 
1.2.1 Background  
Protein secretion is indispensible for the bacterial development and survival. Not only it is 
necessary to build up and modify the bacterial membranes, but it is also a key step of bacterial 
virulence for pathogens and symbionts. Defects in the ability of secretion can render 
pathogenic bacteria non-pathogenic. Six different secretion (type I-VI) systems have been 
identified in gram-negative bacteria so far. All of them differ in their structure as well as in 
their mode of translocation. For instance, the TTSS is able to inject effectors directly into the 
host cell, whereas the Sec pathway transports proteins into the periplasmic space or the outer 
Figure 2: Chlamydial 
developmental cycle. 
Chlamydiaceae undergo a biphasic 
developmental cycle which varies 
between a metabolically inactive 
form, the elementary body (EB) 
and a metabolically active form, 
the reticulate body (RB). EBs 
invade the epithelial host cell and 
convert into RBs within a 
chlamydial-specific compartment, 
the inclusion. RBs divide by 
binary fission, reconvert back to 
EBs and are released at the end of 
the developmental cycle. Duration 
depends on the species. (Pandey et 
al., 2009) 
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membrane (Tseng et al., 2009). The TTSS is a very old type of secretion, which seems to 
have been present in bacteria already over 1 billion years ago (for instance, in Chlamydiae) 
(Cavalier-Smith, 2006; Yoon et al., 2004). Interestingly, in some species the genes encoding 
structural proteins for the TTS apparatus can be on a dedicated plasmid (eg. Shigella) which 
allows frequent LGT of the plasmid to a new species (Buchrieser et al., 2000). In other 
bacteria, as for example Salmonella and Chlamydiae, these genes are located on the bacterial 
chromosome. The very well investigated Salmonella encode the genes on a so-called 
Salmonella pathogenicity island (SPI), also prone to LGT (Shea et al., 1996). However, none 
of it applies to Chlamydiales. Their genes encoding the structural proteins of the TTS 
apparatus are found in three distinct conserved genomic clusters (Stephens et al., 1998).  
Evolutionary studies suggest the conclusion that the contemporary TTSS has either evolved 
from a bacterial flagellum (termed flagellar Type III Secretion System) (Nguyen et al., 2000) 
or coevolved with it from a common ancestor (Aizawa, 2001). All Chlamydiaceae (not 
Parachlamydiaceae) that have been examined so far still have several of these fla-TTS genes, 
even though the bacteria are non-motile. What all chlamydial genomes encode are the 
structural proteins building up the TTS injectisome (a molecular “needle-complex” consisting 
out of 20-25 proteins), the translocator apparatus (the base and a rod-like structure) and 
chaperones which are required for the proper secretion of effectors (Peters et al., 2007; Betts-
Hampikian and Fields, 2010).  This needle-complex can cross three different membranes: the 
bacteria inner membrane, the bacteria outer membrane and the plasma membrane of the host 
cell. For given reasons not all of the TTS subunits have been undoubtedly identified in 
Chlamydiae up to date, but comparison to Yersinia- or Salmonella-machineries can give a 
good structural and functional idea (figure 3, table 2).  
 
Component Predicted structure or function 
CdsC Component of outer membrane ring  
CdsD Integral inner membrane ring protein 
CdsF Needle subunit protein 
CdsJ Predicted lipoprotein; spans the periplasmic space 
CdsL ATPase inhibitor 
CdsN ATPase 
CdsQ Basal body protein; required for structural assembly; homolog of motor-switch protein of fla-
TTS 
CdsR Integral IM protein with multiple transmembrane domains 
CdsS Integral IM protein with multiple transmembrane domains 
CdsT Integral IM protein with multiple transmembrane domains 
CdsU Integral IM protein; by analogy with fla-TTS, associates with CdsJ, CdsN ATPase, and its 
putative negative regulator, CdsL 
CdsV Integral IM protein; belongs to the Flagellar/Hr/Invasion Protein Export Pore (FHIPEP) 
protein family; highly conserved amino terminus has 6–8 predicted transmembrane domains; 
large, less conserved, hydrophilic C terminus, predicted in cytoplasm where it might interact 
with other TTS proteins 
Introduction 
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CopB Translocator protein 
CopD Translocator protein 
CT584 Putative needle tip protein 
Table 2: Components of the chlamydial TTS machinery and their function. IM = inner membrane. (adapted 
from Peters et al., 2007; Betts-Hampikian and Fields, 2010) 
 
 
  
Figure 3: Chlamydial TTS apparatus. Putative structure  obtained by comparison with Yersinia and Salmonella. 
Depicted in parentheses are flagellar paralogs. (Peters et al., 2007; Betts-Hampikian and Fields, 2010) 
 
 
1.2.2 Secretion Signal and Effectors  
The molecular recognition of effectors by the TTS machinery is elusive. Still, the 
identification of a signal that selects for TTS substrates would help to identify effector 
proteins. The detection of novel effectors is an intriguing attempt, since they constitute 
putative virulence factors whose characterisation would lead to a better understanding of 
Chlamydiae and their infections. 
What could this signal consist out of? In all secretion systems examined so far it has been 
revealed that the protein sequence is harboring the signal responsible for a functional 
secretion (Ramamurthi and Schneewind, 2002). If this is also valid for the TTSS is highly 
controversial. Researches argue if the information for TTS is in the mRNA- (mRNA signal 
Effectors, Chaperones 
CdsF 
CT584 
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hypothesis) or in the protein-sequence (peptide signal hypothesis); both theories and their 
mechanisms are depicted in figure 4. Evidence for both exist but seem to be somehow 
contradictory. Anderson and Schneewind (Anderson and Schneewind, 1997) observed that 
frame-shift mutations of amino termini do not abolish transport of effectors, supporting 
strongly the mRNA signal hypothesis. The control test revealed opposite results: Lloyd et al. 
(Lloyd et al., 2001) replaced 17 nucleotides within the first 10 codons of a Yersinia pestis 
effector resulting in a polypeptide, which encodes the same amino acid sequence as the wild-
type one. Interestingly, the secretion signal remained functional. Similar results have been 
obtained for a Salmonella protein (Rüssman et al., 2002). However, it remains elusive if the 
signal lies in a specific secondary structure of the mRNA or in specific features of a 
proteinaceous signal, eg. water accessibility states, amino acid composition, secondary 
structures as coils, helices or strands.  
Both hypothesis could also go hand in hand. It has been suggested by Ramamurthi and 
Schneewind (Ramamurthi and Schneewind, 2002) that some distinct property of the mRNA 
recruits ribosomes to the proximity of the TTS machinery, where translation into an amino 
acid sequence takes place. Other properties of the nascent amino acid sequence then engage 
the TTSS.  
Chaperone dependent processes also play an important role (Cheng et at., 1997). Several 
effectors associate with specific chaperones at the chaperone-binding domain (CBD) and a 
lack of its specific chaperone leads to reduced or abolished secretion (Lee and Galan, 2004). 
Chaperones may prevent the premature association of secreted proteins in the bacterial 
cytoplasm that would target them for premature degradation (Galàn and Collmer, 1999). 
Another function is the triggering of effectors through the narrow TTS conduit (Stebbins and 
Galàn, 2001). In any case, the chaperone seems to remain inside the bacteria during secretion 
of the effector into the host cell and is released by ATPase activity, which was shown for at 
least one case (Akeda and Galàn, 2005). Cheng et al. (Cheng et al., 1997) reported a signal, 
the CBD, located within amino terminal amino acids 15-100 being important (but not 
indispensible) for functional secretion. This CBD-signal seems to be conserved for groups of 
effectors sharing the same chaperone.  
An example of a unique group of effectors is the family of Inc proteins in Chlamydiae. These 
proteins were shown to be secreted by a TTSS and to insert with their hydrophobic domain 
into the inclusion membrane (Subtil et al., 2001). The translocated actin-recruiting 
phosphoprotein (Tarp) is another substrate of the TTSS playing a role in actin-recruitment to 
the inclusion (Clifton et al., 2004) and to the site of entry of the pathogen. Since actin- 
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recruitment is necessary at early stages of internalization Clifton (2004) conceived that the 
needle-complex could be preloaded with this protein prior to infection of the host by the EB. 
 
1.3 In silico Prediction of Effectors  
In silico predictions of effectors can generate candidate lists that can then be subjected to in 
vivo tests. One approach is to screen for homologs of already known effectors between 
different species, based on the hypothesis that they either have a common ancestor or are 
distributed through LGTs (Tobe et al., 2006). A severe drawback is that some distinct effector 
families are unique to specific species or that so far undetected families will be skipped.  
The TTSS as well as the effectors underlie a strictly regulated concerted activation. Next to 
the previously mentioned chaperones, which play an important role as control mechanism for 
temporal order, transcriptional control is also involved (Valls et al., 2006). This may include 
several regulators and sigma factors that bind to their substrate (gene or protein; both post-
transcriptional and post-translational is possible). Once these regulators have been identified, 
identification of their binding sites can lead to the discovery of putative effectors. A 
complication of this approach is the often degenerated and unknown nature of these binding 
sequences.  
Another approach makes use of putative chaperone-effector pairs clustered on the genome 
(Panina et al., 2005). However, it is likely that there exist also chaperone-independent 
substrate recognitions and that not all organisms possess clusters of effectors and chaperones.  
Many experimental data support the hypothesis that the amino terminal sequence of effectors 
is recognized as a signal for TTS. Therefore, deciphering this amino terminal signal appears 
like the easiest way towards the identification of TTS substrates. As it has already been 
mentioned, the amino termini do unfortunately not uncover any obvious sequence similarities 
Figure 4 : Schematic illustration 
of the two hypotheses of the 
location of the amino terminal 
secretion signal: mRNA-based 
(A) and peptide-based (B). In (A), 
the effector mRNA, which carries 
the signal, is synthesized into the 
TTSS during transport. In (B), the 
effector is translated in the 
bacterial cytosol and recognized 
by a peptide born amino terminal 
signal. Chaperones play different 
roles, as enhancing signals or 
holding the protein in an 
unfolded, transportable state. 
Adapted from Arnold et al. (2010) 
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that are common for all known effectors (Arnold et al., 2009). Consequently, a simple 
alignment of the sequences is not sufficient. However, machine learning approaches unravel 
relationships between amino termini and help to identify TTS features that are still puzzling. 
The limiting point is the lack of data they need to be fed with. EffectiveT3 was the first 
prediction software developed for type III secreted proteins (Arnold et al., 2009; Jehl et al., 
2011). 100 amino termini of proteins that were known to be type III effectors were compared, 
and an enrichment of serine, threonine and proline was noted for animal effectors (only serine 
in plant effectors), while leucine residues were underrepresented in the amino termini of both 
groups. A binary classification algorithm was trained to recognize effectors on the basis of 
features as frequencies of amino acids, amino acid properties and short combinations of them 
(Arnold et al., 2009). This approach helps to conduct large-scale screens of prokaryotic 
proteomes and is therefore a valuable tool. 
Cazalet et al. (Cazalet et al., 2004) showed that eukaryotic-like proteins are present in the 
genome of Legionella pneumophila, a facultative intracellular parasite. Ankyrin-rich regions 
typically found in eukaryotes are for example overrepresented in type IV secreted effectors 
(Lurie-Weinberger et al., 2010). Proteins with eukaryotic-like domains are likely to interfere 
with the eukaryotic host cell and may thus represent virulence factors. The software 
“Effective” also takes this into account and detects all protein domains that occur in 
eukaryotes, pathogens and symbionts but not or only rarely in non-pathogens. However, 
large-scale in vitro or in vivo validations of this elegant in silico approach have still not been 
conducted. There are only single examples of pathogens where eukaryotic-like domains were 
detected in secreted proteins. In this work we will perform type III secretion tests on 
candidates that were chosen by the last approach, the “eukaryotic-like domain approach” in 
order to evaluate its potential to identify TTS substrates.  
A short overview of useful methods for in silico predictions of effectors has been given here. 
However, all these methods help to create lists of candidates, but none of them are generally 
applicable.  
 
1.4 In vivo Test of Secretion  
It has largely been explained that sequences of virulence effectors are very diverse. However, 
the TTS machinery seems to be quite conserved, even between very distinct species (Rosqvist 
et al., 1995; Frithz-Lindsten et al., 1998). Based on this observation, the ability of TTS 
effectors to be secreted by a heterologous TTSS of another species was tested. This is of 
particular interest for bacteria such as Chlamydiae that cannot be manipulated genetically. 
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Fields and Hackstadt (Fields and Hackstadt, 2000) showed that the chlamydial protein CopN 
can be secreted by Yersinia enterocolitica. Ho and Starnbach (Ho and Starnbach, 2005) 
confirmed the translocation by a type III secretion system of proteins of C. trachomatis in 
Salmonella enterica. Subtil et al. proved the validity of heterologous TTS of chlamydial 
effectors in Shigella flexneri with a large-scale screen where numerous positive and negative 
controls were included (Subtil et al., 2001 and 2005). In this secretion assay chimeras 
consisting out of the first 20 amino terminal amino acids of chlamydial candidate effectors 
and a reporter gene were transformed into two different Shigella flexneri strains. ipaB is a 
mutant secreting effectors in a deregulated manner (Ménard et al., 1994), whereas the TTSS 
of mxiD is totally impaired (Allaoui et al., 1993). Secretion of chimeras was tested on both 
mutants allowing for differentiation between proteins that are secreted by type III or by one of 
the other pathways.  
 
1.5 Tripartite Symbiosis between Heterotrophic Organism, Cyanobiont and Chlamydiae 
 
1.5.1 Hypothesis  
It is widely accepted that the origin of photosynthetic organelles (plastids) in eukaryotes 
occurred via endosymbiosis of a cyanobiont. About 1 billion years ago a eukaryotic 
heterotrophic cell entered into a symbiontic relationship with a prokaryotic organism and 
instead of phagocytosing it, it took benefit out of the arising symbiosis (Cavalier-Smith, 2006; 
Yoon et al., 2004). Another case of endosymbiosis is the emergence of mitochondria, which 
are derived from -proteobacteria (Gray, 1993). It has been suggested that the nucleus 
developed through endosymbiosis of bacterial or archaebacterial partners as well (Lake and 
Rivera, 1994). Even though there are some examples of this primary endosymbiosis, they stay 
limited. Selection pressure clearly favours organisms, which obtain a new source of energy as 
for example photosynthetic organelles. Still, the establishment of plastids seems to have been 
unique. Progenitors of Archaeplastida (comprising red algae, glaucophyta and green plants, 
all of them possess a functional or remnant plastid) and cyanobionts were quite abundant and 
thus had a lot of possibilities for physical contact. Why is it then such a rare event? 
It has been suggested by Stephen Ball (University of Lille, France) that a key step of this 
metabolic symbiosis was the export of the metabolite ADP-glucose from the cyanobiont to 
the eukaryotic host cell, where it could be stored as polysaccharides, meaning that the host 
cell would benefit from the prokaryotes ability to photosynthesis. Still, ADP-glucose is a 
bacterial-specific metabolite, whereas the eukaryotic equivalent is UDP-glucose. Hence, 
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eukaryotes were not able to further use this metabolite. How can a symbiosis with a 
photosynthetic prokaryote then have been of benefit for the ancestor of Archaeplastida, when 
the latter was not able to use this new source of energy? 
Different scenarios are possible. The archaeplastidal progenitor could have acquired 
appropriate genes from other prokaryotic organisms by lateral gene transfer (LGT) prior to or 
at the time of establishment of a heterotrophic/cyanobacterial symbiosis. Since these gene 
products gained a sudden function in the host cell, selection pressure would have prevented 
their loss.  
Another possibility would be an adaptation of the eukaryotic genes to the new source. This 
includes several mutations and thus a low probability, but considering the idea that the uptake 
of a cyanobiont occurred frequently over a long time, selection pressure would finally 
strongly favour the ones that succeeded.    
Previous phylogenetic studies showed that a surprisingly high amount of archaeplastidal 
genes have their closest homologs in Chlamydiae (21 according to Huang and Gogarten, 
2007; 55 according to Moustafa et al., 2008), more precisely in Candidatus Protochlamydia 
amoebophila UWE25 and Parachlamydia acanthamoeba UV7. According to current 
phylogenetic analysis, Archaeplastida and Chlamydiae do not possess a direct common 
ancestor; the presence of homologs in their genome is thus not a sign for a close relationship. 
Different scenarios to explain this occurrence are conceivable:  
 
1) The cyanobiont received chlamydial genes by LGT prior to the establishment of the 
symbiosis (or vice-versa).  
2) LGT occurred between Chlamydiae and Archaeplastida at a later stage than the plastid 
endosymbiosis. Both directions of gene transfer are thinkable.  
3) Infected insects played the role as vectors introducing chlamydial genes into plants. 
4) A third party (eg. Chlamydiae) was involved at the time of establishment of the 
endosymbiosis (hypothesis of a tripartite symbiosis, supported by Prof. Steven Ball, 
University of Lille, France, unpublished). 
 
Interestingly, chlamydial homologs in the archaeplastidal genome often contain a plastid-
targeting signal (Huang and Gogarten, 2007; Moustafa et al., 2008), promoting the idea of an 
ancestral evolutionary relationship between cyanobacteria (plastids) and Chlamydiae. The 
chlamydial genes found in archaeplastidal genomes clearly have bacterial nature; hence, gene 
transfer has to have occurred from prokaryote (chlamydial or plastid genome) to eukaryote. 
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The hypothesis that a transfer was directed from the cyanobiont versus Chlamydiae can be 
declined by today’s state of knowledge that cyanobacterial homologs are distinct from 
chlamydial homologs that are found in archeaplastidal genomes. Additionally, chlamydial 
proteins are much more related to proteins of other bacteria than to cyanobionts and some of 
the chlamydial homologs are not found in cyanobacteria. Consequently, this would not 
explain the occurrence of close homologs between archaeplastidal and chlamydial genes. 
These reasons suggest gene transfer from Chlamydiae to Archaeplastida or the archaeplastidal 
progenitor (Huang and Gogarten, 2007).  
The hypothesis that LGT of chlamydial genes gave the archaeplastidal ancestor the ability to 
metabolise cyanobacterial products implies that infection with Chlamydiae and the uptake of 
the cyanobiont happened more or less at the same time within the same host cell. This cell 
would have been weakened by the parasitic Chlamydiae, but would also acquire a new source 
of energy, the cyanobiontic ADP-glucose, which could rescue the cell of the deletorious 
effects. The missing link would be enzymes or the respective genes that are contributed by 
Chlamydiae to render a usage of the prokaryotic product for the host cell possible. If this is to 
be true, Chlamydiae introduced these genes to the archaeplastidal ancestor by LGT. 
Phylogenetical analysis of plant-homologs could possibly clarify this point. Moreover, 
secretion of these enzymes by Chlamydiae into the host cell prior to LGT would strengthen 
this hypothesis by extending the time span for a stable integration into the genome. In this 
scenario, the host cell would incorporate a cyanobiont and additionally be infected by 
Chlamydiae, which secretes prokaryotic enzymes for the ADP-glucose metabolism in order to 
hijack the host metabolism. The host cell having the cyanobacterial energy source would 
benefit from this tripartite symbiosis, build up a stable endosymbiosis with the cyanobiont and 
integrate chlamydial genes into its genome. We will further examine the respective 
metabolisms of host cell and Chlamydiae in order to reveal which enzymes could have played 
a role in this scenario. Furthermore, the previously mentioned test of secretion could give 
information whether those enzymes are putative effectors and could have fulfilled the 
function suggested in our scenario.  
 
1.5.2 Glycogen and Starch Metabolism  
Today’s green plants (Chloroplastida, green algae and land plants) use as storage 
polysaccharide starch, which consists out of 20-25% amylose and 75-80% amylopectine. The 
main storage equivalent in animals, fungi, bacteria, archaea and non-chloroplastidal protists is 
glycogen, a closely related but more branched polysaccharide. Interestingly, starch is 
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produced out of ADP-glucose, as is prokaryotic glycogen. In contrast, the base for eukaryotic 
glycogen is UDP-glucose.  
 
1.5.2.1 Glycogen Metabolism in Bacteria and Eukaryotes 
Figure 5 and 6 show the different biochemistry of glycogen metabolism in bacteria and 
eukaryotes (Preiss and Romeo, 1994; Ball et al., 2011). Both need an activated form of 
glucose, glucosyl-nucleotide, which is generated from glucose-1-P. This nucleotide-sugar 
(UDP-glucose for eukaryotes, ADP-glucose for bacteria) is synthesized through the action of 
UDP-glucose pyrophosphorylase and ADP-glucose pyrophosphorylase, respectively. A 
subsequent step of elongation by glycogen synthases leads to a transfer of the activated 
glucose to a pre-existant chain by splitting of the nucleotide. By cleaving some of the -1,4 
linked chains and substituting the bonding by a -1,6 linkage, in both cases branching 
enzymes lead to a delinearization of the macromolecule. The product is the storage 
polysaccharide glycogen. 
Glycogen degradation passes in both cases by an intermediate step of phosphorylase limit 
dextrin, which is produced by the action of glycogen phosphorylases, releasing one glucose-1-
P molecule. Phosphorylase limit dextrin serves as a substrate for debranching enzymes, direct 
debranching enzymes in bacteria and indirect debranching enzymes in eukaryotes. In bacteria, 
this leads to a release of maltotetraose, which can (among others) be used for reactions 
catalyzed by -1,4 glucanotransferases. One possible subsequent pathway results in the 
production of a glucose-molecule and by action of maltodextrin phosphorylase in the release 
of a newly synthesized glucose-1-P.  
In eukaryotes, the next step differ between fungi/animals and amoebozoa. The latter seem to 
use an enzyme (transglucosidase, not depicted in figure 6) which belongs to the same family 
as the bacterial -1,4 glucanotransferases. In any case, indirect debranching enzymes attack 
the outer chains generated on the glycogen particle and transfer them to neighboring glycogen 
chains, meanwhile releasing glucose residues. The newly synthesized long external chains can 
be further recessed by glycogen phosphorylases, producing again glucose-1-P.  
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Figure 5: Glycogen metabolism in prokaryotes. 
 
 
 
 
 
Figure 6: Glycogen metabolism in eukaryotes. 
 
 
1.5.2.2 Starch Metabolism in Chloroplastida 
As mentioned above, starch in Chloroplastida is derived from ADP-glucose (figure 7) (Ball 
and Morell, 2003; Preiss et al., 1987). Chloroplastida are the only eukaryotes that produce and 
metabolize this otherwise bacterial nucleotide-sugar. In general, starch and glycogen synthesis 
is strongly related. Different starch synthases using ADP-glucose as substrate are known: 
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Granule bound starch synthase, soluble starch synthase I/II (SSI/II) and soluble starch 
synthase III/IV (SSIII/IV). Starch synthases build up an amylose chain from activated ADP-
glucose. A subsequent branching step between different amylose chains leads to amylopectine 
and finally the starch particle. This particle can be reshaped (transfer of glucose residues to 
different chains, modification of the glycosidic bonding) or broken down to glucose subunits 
by isoamylases and amylases (starch debranching enzymes). 
 
 
 
Figure 7: Starch metabolism in Chloroplastida. 
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1.6 Objective  
In this work we use the data of the software “Effective” that has kindly been provided by the 
group of Prof. Dr. Thomas Rattei (University of Vienna, Austria). The whole genomes of C. 
trachomatis D/UW-3, Chlamydophila caviae GPIC and Chlamydophila pneumoniae 
CWL029 will be screened for eukaryotic-like domains. The hits will give rise to a pre-
selection of candidates we will reasonably revise in order to obtain a final list of candidates. 
These final candidates will be tested for secretion by a TTSS in a heterologous TTSS of 
Shigella flexneri. We will further compare our obtained secretion results with computational 
predictions of TTS achieved with the software EffectiveT3. A focus on the eukaryotic-like 
domains of positive candidates will probably account for the uncovering of the candidate 
proteins’ function in a eukaryotic host cell.  
Additionally, we will test an assortment of chlamydial proteins engaged in glycogen 
metabolism for secretion into their eukaryotic host. If these enzymes possess TTS signals, it 
could provide strong evidence for an indispensable role of Chlamydiae in today’s plants’ 
history of development. This part of the work is done in collaboration with Prof. Steven Ball 
(University of Lille, France). 
We will further examine if these proteins have different secretion characteristics in C. 
trachomatis and C. pneumoniae, knowing that only C. trachomatis accumulates glycogen. 
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2. Material and Methods 
 
2.1 Material 
 
2.1.1 Equipment 
 
Autoclave Matachana 
Balance Ohaus 
Blotting Gadget BioRad 
Centrifuge Sorvall ThermoScientific 
Centrifuge Heraeus Megafuge ThermoElectron Corporation 
Centrifuge Tabletop 5415D Eppendorf 
Gel Chambers Agarose Gel SubCell Bio-Rad 
Gel Chambers Polyacrylamide Gel Bio-Rad 
GenePulser XCell Bio-Rad 
Hypercassette Amersham Biosciences 
Incubator Memmert 
Microwave Easytronic 
NanoDrop 2000 Labtech 
Pipettes Gilson 
Powersupply Agarose Gel Pharmacia 
Powersupply Polyacrylamide Gel Prolabo 
SmartSpec 3000 Bio-Rad 
Storm Molecular Dynamics 
ThermalCycler 2720 Applied Biosciences 
UV-Light Bio-Rad 
Waterbath Polystat 
 
2.1.2 Expendable Materials 
 
Cuvettes 0,2 cm Bio-Rad 
Expendable Pipettes Costar 
Falcon Tubes Sarstedt 
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Gloves Kimtech 
Hyperfilms MP Amersham GE Healthcare 
Inoculation Loop Sarstedt 
Microcentrifuge Tubes Eppendorf 
Millipore Filter Sartorius Stedim 
Paper 3MM Whatman 
Parafilm Pechiney 
Petri Dish 90mm Graner 
Polystyrene Round-Bottom Tubes Becton Dickinson 
Polyvinylidene Fluoride (PVDF) Membrane  Amersham GE Healthcare 
Sterile Tips StarLab 
Syringe Terumo 
Thermo-Strip 0,2 mL PCR Tubes ThermoScientific 
 
2.1.3 Chemicals 
 
Acrylamide/Bisacrylamide solution (40%) Euromedex 
Agar Difco 
Agarose Sigma 
Ammonium persulfate (APS) Sigma 
β-Mercaptoethanol Merck-Schuchardt 
Bromophenol Blue Sigma-Aldrich 
Chloroform Sigma-Aldrich 
Congo Red Serva 
ECF™ substrate Amersham GE Healthcare 
ECL™ substrate Amersham GE Healthcare 
Ethanol TechniSorv 
Ethylenediaminetetraacetic acid (EDTA) Invitrogen 
Ethidium bromide Eurobio 
Hydrochloric acid Panreac 
Glycerol Sigma-Aldrich 
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2.1.4 Antibiotics 
 
Ampicillin Sigma-Aldrich 
Kanamycin Sigma-Aldrich 
 
2.1.5 Media, Buffer and Solutions 
 
2.1.5.1 Media 
LB plates 
2,5% LB broth base and 1,5% agar are mixed in water and the pH is adjusted to 7,2 with 
NaOH. The mixture is autoclaved at 121°C for 15 min. Before adding antibiotics it has to cool 
down to 56°C (Ampicillin 100 µg/ml, Kanamycin 30 µg/ml). 
 
 
 
Glycine Fluka 
LB broth base Invitrogen 
Phenol Gibco 
Potassium chloride VWR 
Potassium dihydrogen phosphate Rectapur 
Sodium chloride Fluka 
Sodium dodecyl sulfate (SDS) Sigma-Aldrich 
Sodium hydrogen phosphate dihydrate  VWR 
Sodium hydroxide Prolabo 
Tetramethylethylenediamine (TEMED) Euromedex 
Trichloroacetic acid Sigma-Aldrich 
Tris(hydroxymethyl)aminomethane (Tris) Sigma 
Tryptic soy broth Merck 
Tris Acetate EDTA Buffer (TAE) Euromedex 
Tween 20 Sigma-Aldrich 
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LB medium 
2,5% LB broth base are mixed in water and the pH is adjusted to 7,2 with NaOH. The mixture 
is autoclaved at 121°C for 15 min.  
 
Congo red plates 
0,01% Congo Red, 1,5% Agar, 3% Tryptic soy broth are mixed in water and the pH is 
adjusted to 7,3 with NaOH. Instead of autoclaving it, the mixture is boiled three times with a 
time interval of 5 min. Antibiotics are added as described in « LB plates ». 
 
2.1.5.2 Buffer and Solutions 
All buffers and solutions are diluted in pyrolysed water and autoclaved at 120°C for 20 min if 
not designated elsewise. 
 
Phosphate-buffered saline (PBS) 1X 
0,13 M NaCl  
2,68 mM KCL 
6,5 mM Na2HPO4 2H20 
1,46mM KH2PO4 
 
PBS Tween 0,1% 
99,9% PBS 1X 
0,1% Tween 20 
 
Blocking solution  
0,1 g/mL milk powder in PBS Tween 0,1% 
 
Tris 3 M pH 8,8  
3 M Tris adjusted to pH 8,8 with HCl 
 
Tris 2 M pH 6,7 
2 M Tris adjusted to pH 6,7 with HCl 
 
Tris HCl pH 6,8 
2 M Tris adjusted to pH 6,8 with HCl 
 
Running buffer 1X (SDS-PAGE) 
0,2 M Glycine 
25 mM Tris base 
0,1% SDS 20% 
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Transfer buffer (Western Blot) 
25 mM Tris base 
190 mM Glycine 
20% Ethanol  
 
Loading Buffer 5X (SDS-PAGE) 
0,31 M Tris HCl pH 6,8 
10% SDS 
50% Glycerol 
0,05% Bromophenol blue 1% 
 
The ingredients are mixed and heated to 60°C before addition of Bromophenol blue.   
 
Loading Buffer 10X (Agarose gel) 
43,75% Glycerol 87% 
31,25% Bromophenol blue 0,4% 
25% EDTA 0,5 M  
 
 
2.1.6 Enzymes and Antibodies 
 
2.1.6.1 Restrictionenzymes 
 
HindIII  5’-A*AGCTT-3’   
      3’-TTCGA*A-5’ 
Roche 
XbaI      5’-T*CTAGA-3’   
      3’-AGATC*T-5’ 
Roche 
BsaI       5’-GGTCTC(N)1*-3’   
      3’-CCAGAG(N)5*-5’ 
Roche 
 
2.1.6.2 other Enzymes 
 
Prime-Star DNA Polymerase Takara 
GoTaq DNA Polymerase Promega 
T4 DNA Ligase New England Biolabs 
Calf Intestinal Alkaline Phosphatase New England Biolabs 
 
2.1.6.3 Antibodies 
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Anti-cyclase antibody By courtesy of N. Guiso, Institut Pasteur 
Anti-CRP antibody By courtesy of A. Ullmann, Institut Pasteur 
Anti-IpaD antibody By courtesy of C. Parsot, Institut Pasteur 
Horseradish peroxidase-linked antibody  Amersham Pharmacia Biotech 
Alkaline phosphatase-linked antibody Pierce 
 
2.1.7 Marker 
 
1 kb DNA ladder Invitrogen 
Precision Plus Proteins Standard Bio-Rad 
 
2.1.8 Kits 
 
QIAquick PCR Purification Kit Qiagen 
PureLink™Quick Plasmid Miniprep Kit Invitrogen 
 
2.1.9 Organisms and Plasmids 
 
2.1.9.1 Bacteria 
 
Escherichia coli TG1 New England Biolabs 
Escherichia coli DH5α New England Biolabs 
Shigella flexneri ipaB By courtesy of C. Parsot, Institut Pasteur 
Shigella flexneri mxiD By courtesy of C. Parsot, Institut Pasteur 
 
 
 
 
 
 
 
2.1.9.2 Plasmids, Sequences and Chlamydiales Genomes 
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2.1.9.2.1 Plasmids 
 
 
 
2.1.9.2.2 Sequences 
Truncated sequence of calmodulin-dependent adenylate cyclase of Bordetella pertussis used 
for the pUC19cya vector: 
GCCGTGGCGAAGGAAAAAAACGCCACATTGATGTTCCGCCTGGTCAACCCCCATTCCACCAGCCTGATTGCCGAAGGGGTGGC
CACCAAAGGATTGGGCGTGCACGCCAAGTCGTCCGATTGGGGGTTGCAGGCGGGCTACATTCCCGTCAACCCGAATCTTTCCA
AACTGTTCGGCCGTGCGCCCGAGGTGATCGCGCGGGCCGACAACGACGTCAACAGCAGCCTGGCGCATGGCCATACCGCGGTC
GACCTGACGCTGTCGAAAGAGCGGCTTGACTATCTGCGGCAAGCGGGCCTGGTCACCGGCATGGCCGATGGCGTGGTCGCGAG
CAACCACGCAGGCTACGAGCAGTTCGAGTTTCGCGTGAAGGAAACCTCGGACGGGCGCTATGCCGTGCAGTATCGCCGCAAGG
GCGGCGACGATTTCGAGGCGGTCAAGGTGATCGGCAATGCCGCCGGTATTCCACTGACGGCGGATATCGACATGTTCGCCATT
ATGCCGCATCTGTCCAACTTCCGCGACTCGGCGCGCAGTTCGGTGACCAGCGGCGATTCGGTGACCGATTACCTGGCGCGCAC
GCGGCGGGCCGCCAGCGAGGCCACGGGCGGCCTGGATCGCGAACGCATCGACTTGTTGTGGAAAATCGCTCGCGCCGGCGCCC
GTTCCGCAGTGGGCACCGAGGCGCGTCGCCAGTTCCGCTACGACGGCGACATGAATATCGGCGTGATCACCGATTTCGAGCTG
GAAGTGCGCAATGCGCTGAACAGGCGGGCGCACGCCGTCGGCGCGCAGGACGTGGTCCAGCATGGCACTGAGCAGAACAATCC
179  Apa BI
179  Bst API
183  Nde I
396  Apo I
396  Eco RI
402  Cla I
410  Hpa I
511  Bst BI
582  Psr I
600  Bbr 7I
600  Bbs I
672  Age I
747  Bmg BI
815  Bcl I
887  Sse 232I
1065  Eco RV
1146  Bsg I
1272  Fal I
1301  Sac II
1359  Ava I
1359  Nli3877I
1451  Bst XI
1635  Xba I
1645  Bsp MI
1646  Sbf I
1647  Pst I
1653  Sph I
1659  HindIII
1871  Bsa XI
1871  Bsa XI
1895  Sap I
AlwNI  2429
Bsa I  2978
Bpm I  2996
Sca I  3389
Ssp I   3713
Eco O109I  3886
Pss I  3886
pUC19cya
3898 bp
Unique Sites
Figure 8: Vectormap of pUC19cya 
(not depicted Ampicillin Resistance, 
Origin of Replication) 
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Figure 9: Vectormap of GeneArt® pMK 
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TTTCCCGGAGGCAGATGAGAAGATTTTCGTCGTATCGGCCACCGGTGAAAGCCAGATGCTCACGCGCGGGCAACTGAAGGAAT
ACATTGGCCAGCAGCGCGGCGAGGGCTATGTCTTCTACGAGAACCGTGCATACGGCGTGGCGGGGAAAAGCCTGTTCGACGAT
GGGCTGGGAGCCGCGCCCGGCGTGCCGAGCGGACGTTCGAAGTTCTCGCCGGATGTACTGGAAACGGTGCCGGCGTCACCCGG
ATTGCGGCGGCCGTCGCTGGGCGCAGTGGAACGCCAGGATTCCGGCTATGACAG 
 
2.1.9.2.3 Chlamydiales Genomes  
Chlamydophila pneumoniae CWL029: NC_000922 
Chlamydophila caviae GPIC: NC_003361.3 
Chlamydia trachomatis D/UW-3: NC_000117.1  
Parachlamydia acanthamoebae UV7: NC_015702.1 
Candidatus Protochlamydia amoebophila UWE25: NC_005861.1 
 
2.1.9.3 Oligonucleotides 
All oligonucleotides contain restriction sites for HindIII, XbaI or BsaI (underlined): 
 
 Forward Reverse 
CT576 AGTCAAGCTTTTAGGAATTATCGCGATGAGCA AGTCTCTAGACAAGCGGCTACGTGATTTTT 
CT153 AGTCAAGCTTGTTCCTTCCATTATAGGGTGTCA AGTCTCTAGAAGAGAAACGTCCTAATCGTGGA 
CT305 AGTCAAGCTTTTAGGAGTAGTCTGCATGCGCGTAG AGTCTCTAGAAAATTCGACAGCCCCAATCT 
CT035 AGTCAAGCTTATAGAGGCAAAGAGATGAAGCGTAT AGTCTCTAGACTGGAATGGAGCAGCTACCT 
CT460 AGTCAAGCTTCTTTTCTTATCATCTTCTTTAACTAGGAGTC AGTCTCTAGAACCAACGATGGCAGCTAAAT 
CT862-61 AGTCAAGCTTATAGGCCATCTCCAAGAAGTGTCT AGTCTCTAGACATATTATCGGGAAGCGGAC 
CT862-87 AGTCAAGCTTATAGAGGACACCTTTATCTACAACATGC AGTCTCTAGACATATTATCGGGAAGCGGAC 
CPn0811 AGTCAAGCTTTTAGGAATTAGATCGATGAGCAAG AGTCTCTAGATAGACGGCTTCGCGTTTTT 
CPn0091 AGTCAAGCTTAAGATAGAACTCCGGAAAGCAA AGTCTCTAGAACCAAGCTCTCTACTTGCAGAA 
CPn0128 AGTCAAGCTTATAGCGCTTTTCTGTTCGAGAGG AGTCTCTAGAACGTATCGTATGCCGTAAATAATA 
CPn0489 AGTCAAGCTTGTTACAATGGAGGATTGGCTAAG AGTCTCTAGAACACGCTGTGACCTCATCC 
CPn0577 AGTCAAGCTTGTAGTCAGGTCTCTTCTTACCACCTT AGTCTCTAGACATAGGTCCCTTGCCAACTA 
CPn0769 AGTCAAGCTTATAGAGGTCCTCACGCAATTAGATTA AGTCTCTAGAGGCAAAAACAAATTCACTCC 
CPn0856 AGTCAAGCTTGGATCAAGAGATAGGAACGTAAGG AGTCTCTAGATATGGCTTTGAGCTTATCTGC 
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2.1.9.4 Genes synthesized by GeneArt® Gene Synthesis 
GeneArt® Gene Synthesis synthesized the amino terminal sequences of the genes derived 
from Parachlamydia acanthamoebae and Candidatus Protochlamydia amoebophila genome 
CPn1018 AGTCAAGCTTCTGGTTTACAAGTGGAAAATGA AGTCTCTAGACTTGGCAAGTAAGCCTAAAGAC 
CPn1021 AGTCAAGCTTATAGAGGACACCTTCATTTACAACCTACG AGTCTCTAGAATCATCTGGGAAAGGGAAGTC 
CPn0176 AGTCGGTCTCTAGCTAGGCGAAGTTAAGGAAGCTCTG AGTCTCTAGAAAACTCATAGGAAAAACTAGCTGAA 
CPn0562 AGTCAAGCTTATAGACTACATTCTGCATGAAATTATAAGG AGTCTCTAGACATGGCGATCGAAGGTTTA 
CPn0927 AGTCAAGCTTCTTTTGTTCTCTTTATACTCTGTGTACC AGTCGGTCTCACTAGACGGCTTTGGATCCGTCT 
CPn0928 AGTCAAGCTTAGAGACGTAAGGATTTCGCATT AGTCTCTAGATGACGAAAAATAGGAAACTGG 
CPn0929 AGTCAAGCTTATAGTTAAATTTTATAGGAAAAGTTCATGG AGTCTCTAGAAAAATAAGTCGCTTGTGGAGA 
CCA00743 AGTCAAGCTTATAGACCGATTTACAAGTTGAAGAAGA AGTCTCTAGAATGCATTCCTACTCGCAATA 
CCA00911 AGTCAAGCTTATCTAACATCAAGAGATAGGAACGC AGTCTCTAGAATGCTCTTGATTAATAGACTTGAGTT 
CTMalQ AGTCAAGCTTGTAATAGTTTTGTTTTTATGCCGTCATTATCCCAAT AGTCTCTAGAGCCATGCTTAGGAGAAGTATCTATC 
CTGlgA AGTCAAGCTTGTAATAGTTTTGTTTTTATGAAAATTATTCACACAGCTATCG AGTCTCTAGATGCTAGTCCGTATAGCGCG 
CTGlgC AGTCAAGCTTGTAATAGTTTTGTTTTTATGGCTGGTAGACGGACG AGTCTCTAGATCCGCATAAGACAATAACTCCTAC 
CTGlgP AGTCAAGCTTGTAATAGTTTTGTTTTTATGTATTTCGATCGGACAAAG AGTCTCTAGATTGAGGAGTCTGGACTACCC 
CTGlgX AGTCAAGCTTGTAATAGTTTTGTTTTTATGGAATCTTTGTCTGTTCGTT AGTCTCTAGAAGAAAATAGAGAAAAACGGTAGCG 
CTGlgB AGTCAAGCTTGTAATAGTTTTGTTTTTATGGATCCTTTTTTCTTAAATACTCAAC AGTCTCTAGAAGAAACAATTCCCAAAAGATCTTG 
CPnGlgX AGTCAAGCTTGTAATAGTTTTGTTTTTATGGAAAAAGTTTCTTCTTATCCC AGTCTCTAGAAGCATATAAAGCAAATCGATAGC 
CPnGlgA AGTCAAGCTTGTAATAGTTTTGTTTTTATGAGAATCGTACAAGTCGCTGT AGTCTCTAGATAACTCCTTAGATAGACTAGCTACAGCATC 
CPnGlgB AGTCAAGCTTGTAATAGTTTTGTTTTTAGTGTTGATAAACTGATCCATCC AGTCTCTAGAAGCAAGGATCCCTAAGAGTTTATG 
CPnGlgC AGTCAAGCTTGTAATAGTTTTGTTTTTATGATAGAAAACGATTTTCCGG AGTCTCTAGACCCTCCACACAAGATAATTACTCC 
CPnMalQ AGTCAAGCTTGTAATAGTTTTGTTTTTATGAATGTTTTAAAATACACAAAACACTC AGTCTCTAGATGGGAGATAAATCCCGTGTTTA 
CPnGlgP AGTCAAGCTTGTAATAGTTTTGTTTTTATGGAAGATTTTTCGAGTTTTGATAA AGTCTCTAGATACAACACTTAAATACAGACGATCTAAAA 
ParaGlgAΔ10 AGTCAAGCTTGTAATAGTTTTGTTTTTATGGCACCACTTGCCAAAGTC GGTACCTCTAGATAGTTCACGAGAGAG 
ParaMalQBIS AGTCAAGCTTGTAATTACTGAGGAATGGTAACGATGACAAACTTTTT AGTCTCTAGAGAAAATGGGAAGGCAAA 
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(all inserts are listed in the appendix). Inserts were integrated into the pMK vector bearing a 
Kanamycin resistance. By performing a restriction digest we cleaved out the insert and ligated 
it into pUC19cya (see 2.2.1.5 and 2.2.1.6). 
 
2.1.10 Computer Programs, Softwares and Databases  
 
2.1.10.1 Computer Programs and Softwares 
- DNA-Strider 1.4f3 : work on DNA and protein sequences 
- Primer3Plus : primer design 
- Quantity One : Visualization of agarose gel bands  
- National Center for Biotechnology Information  http://www.ncbi.nlm.nih.gov/ : nucleotide   
BLAST 
 
2.1.10.2 Databases 
- National Center for Biotechnology Information  http://www.ncbi.nlm.nih.gov/ :  genomes 
- Effective  http://effectors.org : effector predictions 
 
2.2 Methods 
 
2.2.1 Cloning Methods 
The following cloning methods are listed in a chronological order to obtain chimeras of the 
candidate proteins which were then tested for secretion. Chimeras consisted out of the 
approximately first 20 amino terminal amino acids of the candidate protein (20 N-ter) and a 
truncated form of the calmodulin-dependent adenylate-cyclase (Cya) of Bordetella pertussis 
(figure 10; see 2.1.9.2.2 for its sequence). All constructs were verified by sequencing (all 
inserts are listed in the appendix).  
 
Material and Methods 
 
 27 
 
 
 
2.2.1.1 Constructs and Primer Design 
 
2.2.1.1.1 Constructs  
The FASTA nucleotide sequence in NCBI of each candidate was taken and saved as a DNA-
Strider file. Complement sequences were transformed into the antiparallel strand. After 
having transcribed them into amino acids the largest open reading frame (ORF) was assumed 
to depict the protein. Approximately the first 20 amino terminal amino acids from the start-
codon on were taken into account and screened for restriction sites with HindIII and XbaI 
(BsaI if the sequence was cut by one of the first two).  
 
2.2.1.1.2 Primer Design 
In order to design primers for the subsequent Polymerase Chain Reaction (PCR) the software 
Primer3Plus was used. Our inserts were to be ligated into vector pUC19cya, that possesses an 
α-Galactosidase (α-Gal) site upstream of the ligation site which we did not want to be 
expressed. For this reason we were looking for stop-codons in frame with α-Gal located at 
least 10 and maximum 21 bases upstream of the start-codon of our candidate sequence. In 
case of absence a stop codon had to be integrated into the forward primer. We avoided the 
sequences to be in frame with the α-Gal site. The forward primers contained also a HindIII 
restriction site for further cloning procedures. The reverse primers featured a XbaI restriction 
site to put the insert in frame with the on the vector downstream located cyclase-tag (cya, 
calmodulin-dependent adenylate cyclase of Bordetella pertussis). In two cases a BsaI 
restriction site had to be integrated instead of HindIII and XbaI, respectively. The melting 
temperatures (Tm) for the primers were chosen in a range from 55° to 63° C. 
 
20 N-ter Cya 
HindIII XbaI 
pUC19cya 
Figure 10: Scheme of pUC19cya-chimera. The 
nucleotide sequence of the 20 amino terminal 
amino acids are cloned into the vector 
pUC19cya by using HindIII and XbaI 
restriction sites.  
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} 
2.2.1.2 Polymerase Chain Reaction (PCR) 
The Polymerase Chain Reaction is a technique in molecular biology to amplify pieces of 
DNA. This can be used to detect the presence or absence of a certain piece or for cloning 
methods. In this work parts of the C. caviae, C. pneumoniae and C. trachomatis genome, 
respectively, were amplified producing the sequences of interest flanked by two restriction 
sites. A DNA Polymerase with high fidelity was chosen. 
 
PCR machine : 2720 Thermal Cycle, Applied Biosystems 
 
Reaction mix (per tube) : 
Buffer Prime-Star 5x 5 µL 
dNTP (2,5 mM) 2,5 µL 
Prime-Star DNA Polymerase (2,5 U/µL) 0,25 µL 
Forward Primer (10 µM) 1 µL 
Reverse Primer (10 µM) 1 µL 
Template DNA (10-100ng) 0,25 µL 
ddH2O 16 µL 
Total 25 µL 
 
PCR conditions : 
 
 
For runs with a less accurate DNA Polymerase (to validate the presence of a certain insert for 
example) the DNA Polymerase GoTaq was used. 
 
Reaction mix (per tube): 
Buffer GoTaq 5x 5 µL 
MgCl2 2 µL 
dNTP (2,5 mM) 0,5 µL 
GoTaq DNA Polymerase (5 U/µL) 0,13 µL 
Forward Primer (10 µM) 2 µL 
Reverse Primer (10 µM) 2 µL 
Template (boiled bacteria) 5 µL 
ddH2O 8,37 µL 
Total 25 µL 
 
First Denaturation 98°C 5 min 
Denaturation step 98°C  10 s 
Annealing step 55°C 10 s 
Elongation step 72°C 1 min 
30 cycles 
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} 30 cycles 
PCR conditions :  
First Denaturation 95°C 5 min 
Denaturation step 95°C  30 s 
Annealing step 55°C 60 s 
Elongation step 72°C 60 s 
Final Elongation 72°C 10 min 
  
 
2.2.1.3 Electrophoretical Separation of DNA Molecules by means of an Agarose Gel 
This technique is used to separate DNA or RNA fragments according to their size. Agarose in 
a concentration of 1-3% is put in Tris Acetate EDTA Buffer (TAE) and carefully heated in the 
microwave until everything is dissolved. The solution is poured into a gel chamber. After 
cooling down the gel is solid and samples can be run at a constant voltage from 80-120 V 
with TAE as running buffer. The gel is then incubated in water or TAE with ethidium 
bromide (1-10 µg/mL) for 15 min and washed twice with water or TAE. Afterwards the bands 
are revealed under UV-light.  
 
2.2.1.4 Purification of PCR Products  
In order to remove the reagents of a previous PCR reaction and to have the DNA sufficiantly 
purified for a subsequent restriciton digestion QIAquick PCR Purification Kit is used. By a 
simple bind-wash-procedure DNA fragments in a range of 100 bp to 10 kb can be purified 
with a yield of up to 95%.  
Five volumes of binding buffer (PB) are added directly to the PCR reaction and the mixture is 
applied to the silica based spin column. The high-salt conditions provided by the buffer lead 
to an adsorption of the DNA to the silica-gel membrane and impurities can be washed away 
with the buffer PE. The bound DNA is eluted with 30 µL of water. 
 
2.2.1.5 Restriction Endonucleases 
Restriction endonucleases are enzymes that specifically recognize DNA sequences (restriction 
sites) and hydrolyse the DNA backbone producing either sticky or blunt ends. Different 
providers recommend different reaction conditions and temperatures depending on the 
enzyme, therefore the respective conditions should be consulted prior to an experiment. 
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2.2.1.5.1 Digestion of PCR and GeneArt® Products 
Purified PCR products and GeneArt® plasmids with insert were digested with HindIII and 
XbaI (or BsaI if the construct possessed a restriction site for one of the others) in order to 
ligate them into the vector.  
 
Reaction mix (per tube) :  
HindIII/XbaI BsaI/XbaI HindIII/BsaI 
Buffer 2 10x 2 µL Buffer 2 10x 2 µL Buffer 2 10x 2 µL 
BSA 100x 0,2 µL BSA 100x 0,2 µL BSA 100x 0,2 µL 
HindIII (10 U/µL) 0,1 µL   HindIII (10 U/µL) 0,1 µL 
XbaI (10 U/µL) 0,1 µL XbaI (10 U/µL) 0,1 µL   
H2O 1,6 µL H2O 1,6 µL H2O 1,6 µL 
DNA 16 µL DNA 16 µL DNA 16 µL 
Digestion : 90 min 37°C 
                                     Buffer 3 10x 1 µL 
                                     BsaI (10 U/µL) 0,2 µL 
 
Digestion : 60 min 50°C 
Inactivation : 30 min 65°C 
Buffer 2, 3 and BSA 100x : New England Biolabs  
 
DNA: either 16 µL of PCR-product or 0,5 µg of GeneArt® plasmid. 
 
2.2.1.5.2 Digestion and Phosphorylation of Vector 
The vector pUC19cya was digested with HindIII and XbaI and two phenol/chloroform 
extractions were performed. The vector was precipitated with ethanol and treated with calf 
intestinal alkaline phosphatase to prevent self-ligation. Again two phenol/chloroform 
extractions and a precipitation step with ethanol were conducted and the DNA is diluted in 40 
µL of Buffer TE. 
 
2.2.1.6 Ligation of Insert and Vector 
In cloning procedures ligases are applied to create a phosphodiester bond between two 
double-stranded DNA fragments. This offers the possibility to integrate an insert of interest 
into a specific vector. As a rule of thumb the ratio « insert : vector » is in a range from 1 : 1 to 
3 : 1.   
For 10 µL of ligation mix with T4 DNA Ligase (New England Biolabs) the reaction buffer (1 
µL), the T4 DNA Ligase (0,05 µL, 400 U/µL), nuclease free water, vector pUC19cya (∼0,025 
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pmol) and insert (∼0,075 pmol) are carefully mixed and incubated at 16°C for at least 30 min 
(up to overnight).  
 
2.2.1.7 Transformation in Escherichia coli  
A transformation in general is the uptake of free DNA by competent bacteria. This procedure 
can be applied for different purposes, among it the amplification of a plasmid. Different 
methods can be used, which differ in the choice of bacteria and reaction conditions. The used 
methods here are the so-called Heat-Shock Transformation and the Electroporation. 
 
2.2.1.7.1 Heat-Shock Transformation in TG1 
Ligated plasmids are amplified in heat-shock competent E. coli TG1. For this purpose 7 µL of 
the ligation products are mixed with 40 µL of TG1, kept on ice for 30 min and transferred to 
42°C for exactly 45 s. The sample is immediately put back on ice and as fast as possible 300 
µL of LB medium are added. In order to allow bacteria to divide and to produce the antibiotic 
resistance they are incubated on 37°C for 40 min. 60 to 300 µL of the mixture are plated out 
on LB plates with the respective antibody for selection and put in a 37°C incubator overnight.  
 
2.2.1.7.2 Electroporation in DH5α 
Electroporation with electroporation competent E. coli DH5α is used to amplify plasmids. An 
externally applied electric field leads to a permeabilization of the cell membrane, rendering 
DNA uptake possible. 40 µL of DH5α are mixed with 10-100 ng DNA, transferred to a 2 mm 
cuvette and pulsed with BioRad GenePulser (2500 V, 25 µF, 200 ). Cells are immediately 
put back on ice and 300 µL of LB medium are added. In order to allow bacteria to divide and 
to produce the antibiotic resistance they are incubated on 37°C for 40 min. 60 to 300 µL of 
the mixture are plated out on LB plates with the respective antibody for selection and put in a 
37°C incubator overnight. 
 
2.2.1.8 Purification of Plasmid via Miniprep 
The used PureLink™Quick Plasmid Miniprep Kit renders it possible to isolate plasmids out 
of a bacterial culture. For this purpose 1,5 mL of an overnight culture are pelleted (5 min, 
13200 rpm) and resuspended in resuspension buffer. Cells are lysed via an alkaline/SDS 
procedure with lysis buffer. The precipitation step occurs with the respective precipitation 
buffer and after centrifugation the supernatant is applied to a silica membrane column that 
selectively binds plasmid DNA. Two washing steps with washing buffers remove the 
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contaminants. The bound DNA is eluted with 30 µL of water and stored at either -20°C or 
4°C (to avoid frequent freezing/thawing). 
 
2.2.2 Working with Shigella flexneri 
Shigella flexneri belong to the part of family of enterobacteriaceae which are able to secret 
the Shiga-toxin. Therefore they should be handled with care.  
 
2.2.2.1 Preparation of electrocompetent ipaB and mxiD 
The procedure for both strains is identical and has to be carried out on ice or 4°C. 
5 mL of an overnight culture (30°C) are seeded out in 500 mL of LB broth/antibiotic. After 
about 3 h at 37°C the culture should have an optical density (OD at 600 nm) between 0,6 and 
1. Cells are centrifuged at 6000 rpm for 10 min at 4°C and the supernatant is removed. The 
pellet is resuspended in 250 mL of icecold water and centrifuged again. This washing step has 
to be carried out twice. Afterwards one washing step with water/glycerol 10% for 15 min 
4000 rpm is conducted and the pellet is resolved in 2 mL of water/glycerol 10%. Aliquots of 
the now electrocompetent bacteria are made and stored at -80°C. 
 
2.2.2.2 Transformation in Shigella flexneri via Electroporation  
Same procedure as for E. coli DH5α, see 2.2.1.7.2. 
 
2.2.2.1 Growing of Shigella flexneri ipaB and mxiD 
Shigella flexneri ipaB and mxiD liquid cultures were grown at 30°C overnight before shifting 
them to 37°C. By experience this decreases the risk of losing the plasmid encoding the TTSS.  
Shigella flexneri ipaB were grown on Congo Red plates. Colonies that possess the TTSS 
plasmid turn red upon secretion, non-secreting colonies are bigger in size and white.  
 
2.2.3 Test of Cloning Efficiency by PCR 
To validate the presence of the candidate sequences in Shigella flexneri a PCR with the 
respective primers is run. One colony of a plate is picked, put in 35 µL of water and boiled for 
5 min. 5 µL are taken to serve as template. For reaction mix and PCR conditions see 2.2.1.2 
GoTaq. 10 µL of the PCR products are run on a 3% agarose gel.  
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2.2.4 Secretion Test 
 
2.2.4.1 Solid Test 
Shigella flexneri ipaB colonies transformed with different constructs were picked in the 
morning on an LB plate with the respective antibiotic and incubated for 8 h at 37°C. In the 
evening the plate was covered with a polyvinylidene fluoride (PVDF) membrane and the 
colonies were allowed to grow overnight at 37°C. The following day the membrane was 
soaked for 5 min into 100% ethanol and washed three times with 0,1% Tween 20 in 
phosphate-buffered saline (PBS). After saturation in blocking solution (see 2.1.5.2) for at least 
30 min at room temperature the membrane was probed with anti-Cya antibody and either 
alkaline phosphatase-linked or horseradish peroxidase-linked secondary antibodies. For 
revelation procedure and the exact usage of antibodies see 2.2.5.3 and 2.2.5.2, respectively. 
 
2.2.4.2 Liquid Test 
1 mL of a 30°C overnight culture of Shigella flexneri ipaB or mxiD transformed with different 
constructs was inoculated in 30 mL of LB broth/antibiotic and incubated at 37°C for 4 h. 1 
mL was removed and pelleted (5 min, 13200 rpm). The pellet was then resolved in 500 µL of 
loading buffer (see 2.1.5.2) and boiled for 20 min before being stored at -20°C. 25 mL of 
overnight culture were centrifuged for 20 min at 4000 rpm and 4°C. The supernatant was 
filtered with a Millipore filter (0,2 µm) attached to a syringe. To precipitate the proteins 3 mL 
of trichloroacetic acid were added and allowed to incubate on ice for 30 min. The sample was 
centrifuged for 15 min at 10000 rpm and 4°C, the supernatant removed, the pellet dried and 
resolved in 500 µL of loading buffer with 3 µL of NaOH 10 N in order to adjust the pH. 
Before storing them at -20°C they were boiled for 5 min. 
 
2.2.5 Protein-Biochemical Methods 
 
2.2.5.1 Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
SDS-PAGE is a means to separate proteins according to their size in an electric field. Since 
proteins possess, unlike nucleic acids, varying charges and shapes according to their 
secondary and tertiary structures, they may not migrate into the polyacrylamide gel at similar 
rates. Therefore the proteins are usually denatured and coated with a negative charge, so that 
their separation is now dependent on the size. Sodium dodecyl sulfate (SDS) is a detergent 
that fulfills both functions, and is added to the sample as an ingredient of the loading dye.   
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The gel itself consists out of an acrylamide/bisacrylamide solution (40%), which upon 
polymerization builds up a dense mesh with concentration-dependent pore size, tris (hydroxy 
methyl) aminomethane (Tris) as buffer, SDS, water, TEMED (N, N, N', N'-
tetramethylethylenediamine) that accelerates the polymerization and APS (Ammonium 
persulphate) to initiate the reaction. APS and TEMED are added at the very end. 
The gel is composed of two different parts : the upper part called stacking gel leads to a 
concentration of the proteins on a thin starting zone, the lower part (running gel) leads to a 
separation of the proteins according to their size. This difference is obtained by the usage of a 
low percentage gel (big pores) and a lower pH for the stacking gel.  
The samples are mixed with the loading dye and 5% β-mercaptoethanol which has the 
capacity to cleave disulfide bonds and boiled for 5 min. They are loaded on the gel, the gadget 
filled with migration buffer and run at 100-130 V. 
 
Valid for one gel : 
 8% Running gel 12% Running gel Stacking gel 
Tris 3M pH 8,8  950 µL 950 µL - 
Tris 2M pH 6,7 - - 156 µL 
SDS (10%) 75 µL 75 µL 25 µL 
acrylamide/bisacrylamide (40%) 1,5 mL 2,25 mL 235 µL 
Water 4,95 mL 4,15 mL 2,06 mL 
APS (10%) 75 µL 75 µL 25 µL 
TEMED 7,5 µL 7,5 µL 2,5 µL 
 
 
2.2.5.2 Western Blot 
The western blot is a widely used analytical technique to detect specific proteins in a given 
sample. Proteins coated with a negative charge are transferred from a polyacrylamide gel to a 
PVDF membrane via an electric current (electroblotting) where they are probed using 
antibodies specific to the target protein.  
The used blotting apparature is the so called tank-blotting system (in contrast to a semi-dry 
blot). Therefor the PVDF membrane is activated by soaking it with 100% ethanol for 5 min. 
After washing it twice with water the « sandwich » can be assembled, consisting out of 
Whatman filter paper (3 layers), PVDF membrane, gel and again 3 layers of Whatman filter 
papers, all soaked in transfer buffer. The sandwich is put in the appropriate gadget and the 
whole tank-blotting system is filled up with transfer buffer. The transfer takes place at either 
30 V overnight or 120 V for  1-1,5 h (depending on the percentage of the gel). 
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Since the membrane has the ability to bind every protein a subsequent step has to be 
undertaken to prevent the membrane to bind to other proteins than the ones present in the gel. 
For this purpose the membrane is blocked after the transfer for at least 30 min in a saturating 
blocking solution before being probed with antibodies.  
Primary antibodies conduct a protein-specific binding. The used secondary antibodies bind to 
the primary antibody and are linked to a reporter enzyme which when exposed to an 
appropriate substrate allows the detection of the protein. Both antibodies are diluted in 0,1% 
Tween 20 in phosphate-buffered saline (PBS). Between and after the incubation of the 
membrane with the different antibodies (1 h at room temperatur each) 3 washing steps with 
0,1% Tween 20 in phosphate-buffered saline (PBS) for 10 min were conducted. The solutions 
of primary antibodies were reused and stored at -20°C. For secondary antibodies either 
alkaline phosphatase-linked or horseradish peroxidase-linked antibodies were applied.  
 
2.2.5.3 Revelation of PVDF membranes 
 
2.2.5.3.1 by Storm™ 
The adequate substrate in case of labelling with alkaline phosphatase-linked secondary 
antibodies is ECF™ substrate which is applied dropwise (∼1 mL/membrane) on a plastic 
membrane. After treatment with antibodies the PVDF membrane is put with the protein side 
down on the substrate drops and incubated for 1 min. The proteins on the PVDF membrane 
can now be visualized by Storm™. 
 
2.2.5.3.2 with a film 
Horseradish peroxidase is used to cleave a chemiluminescent agent (ECL™ substrate) which 
can be visualized by placing a sensitive sheet of photographic film against the membrane. 
Exposure to the light leads to an image of the antibodies bound to the blot.  
The procedure for adding the substrate can be seen under 2.2.5.3.1. 
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3. Results 
It has largely been shown that Chlamydiae use a TTS machinery to translocate effector 
proteins into the host cell, provoking different effects which are up to date still subject to 
many investigations. Due to a lack of genetic tools to manipulate Chlamydiae a wide screen 
of putative effectors has only once been attempted so far, even though the revelation of 
potentially secreted proteins could open the field for further functional studies (Subtil et al., 
2005).  
In this work we apply a TTSS-screen on 46 different candidates of 5 different species of the 
order Chlamydiales. This screen is based on the fact that effectors can be secreted by a 
heterologous TTSS, meaning that the candidates can also be secreted by another bacterium 
possessing a TTSS (Subtil et al., 2001). We chose Shigella flexneri for our experiments and 
designed 51 constructs for our 46 candidates. Some candidates were tested with two 
constructs because the translational start was ambigous.  
The selection of the candidates was made from two different aspects. For one series they were 
selected based on the presence of eukaryotic-like, for the other series we chose the candidates 
according to their function in the glycogen metabolism. Both rationales are discussed in more 
detail below.  
 
3.1 Selection of the Candidates 
 
3.1.1 via Computational Analysis 
In order to identify proteins with eukaryotic-like domains, computational analysis of genomes 
of C. caviae, C. trachomatis and C. pneumoniae was performed with the database “Effective“. 
This database classifies all organisms of which completely sequenced genomes are listed in 
the RefSeq md the GenBank database into eukaryotes, pathogens, symbiotic and non-
pathogenic bacteria (Jehl et al., 2011). The whole proteomes of C. caviae, C. trachomatis and 
C. pneumoniae were screened and eukaryotic-like domains extracted using signatures 
detected by Pfam. The calculation was restricted to protein domains which are detected in 
pathogenic/symbiontic genomes as well as in at least 3 eukaryotic genomes, in order to 
eliminate the influence of bacterial contaminations in eukaryotic genomes.  
Each detected domain annotated with its Pfam name yields a specific score. This so called 
domain enrichment score S is calculated as the number of standard deviations σ of the 
background frequency in non-pathogen genomes in which the domain frequency in that 
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particular pathogenic/symbiontic genome n differs from the background frequency η in non-
pathogen genomes:  
S = (n - η) / σ 
 
This score allows distinguishing between domains that are uniformly distributed over 
eukaryotic, non-pathogenic and pathogenic genomes and domains that are only or mainly 
present in eukaryotes and pathogens/symbionts. Domains with a score higher than 3 were 
considered to be enriched and taken into account, which resulted in 38 hits for the genomes of 
C. caviae (12 hits), C. trachomatis (10 hits) and C. pneumoniae (16 hits). Domains 
exclusively found in pathogens/symbionts and eukaryotes get a score of 10000. 
For all these hits a computational prediction of TTS signals was performed. Only few type III 
effectors are known so far, mainly due to the fact that the secretion signal is still puzzling. 
According to the best established model that the first 20 amino terminal amino acids of a 
protein determine its ability to be secreted by this system, we used the EffectiveT3 software, 
which is accessible through the database “Effective”. This software detects putative TTS 
signals using an algorithm that is trained to divide secreted and non-secreted proteins by 
rating a combination of discriminative sequence properties of the amino termini. The score 
gives a value between 0 and 1 for each candidate, 1 being the most confident for secretion. 
The cut-off value was set at 0.99.  
In table 3 all 38 hits for the extraction of eukaryotic-like domains are depicted with their locus 
tag, EffectiveT3 score T3, the evaluation of this score considering its cut-off, Pfam of the 
eukaryotic-like domain and the domain enrichment score S. For clearer view the candidates 
predicted to be secreted are highlighted in yellow, the non-secreted in blue.  
 
 
Locus tag T3 T3 Pred. Pfam S
C. caviae 
CCA00164 0,996046511 Y PF02201 5
CCA00180 0,999893146 Y PF05677 10000
CCA00261 1 Y PF10275 10000
CCA00718 0,999987251 Y PF02902 17
CCA00911 0,999999154 Y PF01704 4
CCA00254 0,437064582 N PF03690 5
CCA00648 2,60E-07 N PF09825 5
CCA00681 1,02E-07 N PF01496 4
CCA00740 7,92E-06 N PF07720 4
CCA00743 6,22E-06 N PF08123 7
CCA00952 0,095512048 N PF07720 4
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CCA00988 1,75E-13 N PF02201 5
C. pneumoniae
CPn0577 0,99824817 Y PF02201 5
CPn0811 0,999875252 Y PF07720 7
CPn0856 0,99306126 Y PF01704 4
CPn0928 0,999029796 Y PF05677 10000
CPn0929 0,999997291 Y PF05677 10000
CPn0091 9,67E-07 N PF01496 4
CPn0128 1,05E-04 N PF09825 5
CPn0176 3,57E-10 N PF01823 10
CPn0483 1,84E-06 N PF10275 10000
CPn0489 0,297280059 N PF03690 5
CPn0562 8,84E-09 N PF05677 10000
CPn0769 1,68E-08 N PF02201 5
CPn0887 5,00E-15 N PF07720 7
CPn0927 0,905041597 N PF05677 10000
CPn1018 5,27E-10 N PF08123 7
CPn1021 3,65E-06 N PF07720 7
C. trachomatis
CT576 0,99828678 Y PF07720 4
CT867 0,9988277 Y PF02902 34
CT868 0,999995295 Y PF02902 34
CT035 5,77E-08 N PF09825 5
CT153 4,18E-08 N PF01823 10
CT305 2,32E-11 N PF01496 4
CT386 0,293770526 N PF03690 5
CT460 0,618098361 N PF02201 5
CT643 9,00E-15 N PF02201 5
CT862 0,856131679 N PF07720 4
 
Table 3: Extraction of eukaryotic-like domains in C. caviae, C. trachomatis and C. pneumoniae. Extraction of eukaryotic-like domains and 
prediction of TTS signals were performed with “Effective”, cut-off values amounted to 4 and 0,99, respectively. Proteins are given with 
their locus tag, domains with their Pfam name. S = domain enrichment score, T3 = EffectiveT3 score, Proteins predicted to have a TTS 
signal are yellow, the rest blue. 
 
We aligned all homolog proteins being part of these hits between the three different species 
on NCBI Blast and checked for their consistency regarding the first 20 amino terminal amino 
acids. Proteins being very conserved between two or all three species were supposed to have 
the same secretion properties and only one construct for the subsequent screen was designed 
(Subtil et al., 2005). Table 4 depicts all homologs amongst the 38 hits highlighting in green 
the ones that were very conserved, and in this case giving an alignment of the first 20 amino 
terminal amino acids. 
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Chlamydia 
trachomatis 
Chlamydophila 
caviae 
Chlamydophila 
pneumoniae 
 
CT576 CCA00952 CPn0811  
CT867 CCA00718   
CT868    
CT035 CCA00648 CPn0128  
CT153  CPn0176  
CT305 CCA00681 CPn0091 
CT386 CCA00254 CPn0489 
CT460 CCA00164 CPn0577 
 
MQIPRSVGTHDGSFHADEVT  CT386
MQIPRSIGTHDGSFHADEVT  CPn0489 
 
CT862 CCA00740 CPn1021 
CT643 CCA00988 CPn0769 
 CPn0562 
 
MKKSLIIVESPAKIKTLRKL  CT643
MKKSLIIVESPAKIKTLQKL  CPn0769 
 
 CPn0927  
 CPn0928  
 
CCA00180 
CPn0929  
 CCA00911 CPn0856  
 CCA00743 CPn1018  
 CCA00261 CPn0483  
  CPn0887  
 
Table 4: Homologies between the C. caviae, C. trachomatis and C. pneumoniae hits chosen by “Effective”. Highlighted in green are 
homologs with high conservation. Highlighted in yellow are deviating amino acids. 
 
Hence, two pairs of homologs were sufficiently conserved (CT386 – CPn0489 and CT643 – 
CPn0769), and only one construct of each pair was selected: CPn0489 and CPn0769. 
Amongst the remaining hits we focused mainly on C. trachomatis and C. pneumoniae, 
selecting only two of the C. caviae hits for further examination: CCA00911 and CCA00743. 
The translational start for CT862 was ambigous, so we chose to design two constructs 
(CT862-61 and CT862-87). This gave rise to a set of 26 candidates we chose for the in vitro 
assay of TTS, highlighted the ones which were additionally predicted to have a TTS 
signal (table 5). 
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Chlamydia 
trachomatis 
Chlamydophila 
caviae 
Chlamydophila 
pneumoniae 
CT576  CPn0811 
CT867   
CT868   
CT035  CPn0128 
CT153  CPn0176 
CT305  CPn0091 
  CPn0489 
CT460  CPn0577 
CT862  CPn1021 
  CPn0769 
 CPn0562 
 CPn0927 
 CPn0928 
 
 
CPn0929 
 CCA00911 CPn0856 
 CCA00743 CPn1018 
  CPn0483 
  CPn0887 
 
Table 5: C. caviae, C. trachomatis and C. pneumoniae proteins chosen for secretion tests due to eukaryotic-like domains in their sequence. 
Highlighted in yellow the ones with an additional putative TTS signal. 
 
3.1.2 via their Role in the Glycogen Metabolism 
Considering the hypothesis that a tripartite symbiosis might have been essential for the arising 
of Archaeplastida, we asked the question at which point the selection pressure was so 
favorable compared to the simple symbiosis between heterotrophic organism and cyanobiont. 
The advantage for the host to interrupt phagocytosis of the cyanobiont in order to profit from 
its capability of photosynthesis is obvious – a new source of energy. But this source is only 
within reach if the host can metabolise the cyanobiont’s product, ADP-glucose. It is most 
unlikely that the eukaryotic cell adapted quickly to this new situation by modifying its own 
glycogen enzymes, which use UDP-glucose as a substrate. More likely is the hypothesis that 
these enzymes or their genes were contributed by a prokaryotic partner, either directly by 
LGT, or with a preceding step of secretion of the effectors into the host. Interestingly, no 
other eukaryotes obtained the capacity of using ADP-glucose as substrate.  
According to unpublished data of Steven Ball, the groups of soluble starch synthases (SS) 
III/IV as well as starch debranching enzymes (both archaeplastidal) are derived from 
prokaryotes. Phylogenetic analysis further suggests a chlamydial origin, more precisely a 
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source within the environmental Chlamydiales such as Candidatus Protochlamydia 
amoebophila and Parachlamydia acanthamoeba. These data support additionally a 
monophyly of all Archaeplastida through a common chlamydial LGT.  
The group SSIII/IV is a group of ADP-glucose-utilizing starch synthases that seem to be most 
related to the chlamydial GlgA (glycogen synthase). Furthermore, analysis suggests that 
archaeplastidal starch debranching enzymes are derived from chlamydial GlgX (direct 
debranching enzyme).   
Again, in the scenario of a tripartite symbiosis time and probabilities play an important role. If 
Chlamydiae secrete enzymes (like GlgA and GlgX) into the host, that help this cell to 
metabolise the newly acquired cyanobiont energy source, time pressure would be less. The 
system would then have more time to stably integrate these genes into the host genome via 
LGT. A test of secretion clarifies the point whether these enzymes are putative effectors. 
We chose to test MalQ, GlgA, GlgB, GlgC, GlgP and GlgX of Candidatus Protochlamydia 
amoebophila and Parachlamydia acanthamoeba (except C. P. amoebophila GlgA, for which 
the sequence was highly similar to P. acanthamoeba, C. P. amoebophila GlgC for which the 
amino terminal sequence was to uncertain, and C. P. amoebophila GlgP).  
To gain more insight into the possibly different ways of glycogen metabolism of C. 
trachomatis and C. pneumoniae we also chose to test the previous mentioned 6 different 
glycogen-linked enzymes in these two species.  
Summing it up we had 21 candidates, amongst which we had one with an ambigous 
translation start (P. acanthamoeba MalQ and MalQBis), one for which it was not clear 
whether the gene locus was correctly annotated (P. acanthamoeba GlgP1 and GlgP2) and one 
for which we deleted (additionally to the normal construct P. acanthamoeba GlgA) the first 
10 amino terminal amino acids. This served us as a negative control.  
Table 6 shows all candidates we chose to test, with their protein name and their locus tag.   
 
 Chlamydia 
trachomatis 
Chlamydophila 
pneumoniae 
Parachlamydia 
acanthamoeba 
Candidatus 
Protochlamydia 
amoebophila 
MalQ CT087 CPn0326 PUV_07340 pc0745 
GlgA CT798 CPn0948 PUV_18990 - 
GlgB CT866 CPn0475 PUV_16710 pc1761 
GlgC CT489 CPn0607 PUV_08690 - 
GlgP CT248 CPn0307 PUV_22600 - 
GlgX CT042 CPn0388 PUV_16520 pc1106 
 
Table 6: List of Chlamydia trachomatis, Chlamydophila pneumoniae, Parachlamydia acanthamoeba and Candidatus Protochlamydia 
amoebophila proteins involved in glycogen metabolism chosen for secretion test. Proteins are given with their protein name and their locus 
tag on the genome. 
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3.2 Results of Cloning Step 
We constructed chimeras for each of our C. caviae, C. trachomatis and C. pneumoniae 
candidates consisting approximately out of the first 20 amino terminal amino acids and a 
cyclase reporter molecule.  
Performing a PCR with the respective primers we obtained the 5 prime end of the chimeric 
gene bearing the sequence of chlamydial origin flanked by restrictions sites. The efficiency of 
the PCR reaction was tested on agarose gels. A band at about 120 bp was detected for all of 
our candidates, which corresponds to the expected size of the fragment. In a digestion step 
with restriction enzymes we prepared the PCR products as well as the synthesized genes for 
Candidatus Protochlamydia amoebophila and Parachlamydia acanthamoeba for a 
subsequent ligation into the vector pUC19cya. The ligation product bearing an antibiotic 
resistance as selection marker was transformed into E. coli. Transformation efficiency was 
good for all candidates except for CPn0577 where only very few colonies grew. Expression of 
the chimera was tested by Western Blot, where we could detect the proper band at about 50 
kD for all candidates except CPn0577 and to a much less extent CPn0769. A PCR was rerun 
for CPn0577 and digestion, ligation and transformation steps repeated. Cloning efficiency 
was better but never reached the level of the other samples. Upon transformation into Shigella 
flexneri mutant ipaB and plating on Congo Red plates we could distinguish between colonies 
that lost their plasmid encoding the TTS apparatus (big white colonies) and colonies that 
incorporated our construct and were still in possession of a functional TTSS (little and red). 
About 10-30% of the colonies lost their TTS plasmid. Transformed mxiD were plated out on 
normal LB plates. As control we run a PCR with the bacterial colonies to see whether there 
was no mixing up of the different candidates. All constructs except the ones that were 
designed with GeneArt® were verified by sequencing. The first PCR was run with GoTaq, 
where the sequencing revealed 5 mutated constructs out of 27. The PCR for these candidates 
was rerun with Prime-Star. At a second PCR run CPn1018 still incorporated a mutation and 
was discarded of the list. The chimeras of CT868, CT867, CPn0887 and CPn0483 were 
already available. Out of a total of 51 constructs to be designed and cloned, only one failed.  
 
3.3 Secretion Test of “Effective” candidates 
The main goal of this work was to test candidate proteins for secretion via a TTSS. The 
secretion tests assume the universality of the secretion signal recognized by TTS machineries, 
giving the possibility to use a heterologous TTSS. The chimeras consisting out of the first 20 
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amino terminal amino acids and the cyclase reporter molecule were tested in Shigella flexneri, 
revealing the properties of their secretion by a TTS machinery.  
   
3.3.1 Solid Test 
The solid test of secretion is a possibility to screen rapidly for secretion for a big amount of 
candidate proteins. The chimeras were transformed into the Shigella flexneri strain ipaB and 
colonies grew overnight on a LB plate covered with a PVDF membrane, which was probed 
with the antibody against the cyclase reporter molecule the day after. Secreted chimeras 
appeared as a halo surrounding the dot where the colony grew, giving sometimes a very clear 
signal, sometimes a signal harder to define. Chimeras that were not secreted at all just 
appeared as the dot where the colony grew.  
Importantly, previous experiments revealed that the occurrence of 
false positives is below 5% (Subtil et al., 2005). The solid test was 
exclusively performed for the C. pneumoniae, C. caviae and C. 
trachomatis candidates (for which we obtained clones) possessing a 
eukaryotic-like domain. Five constructs for which no results are 
available had a mutation at that time and were only subjected to the 
next test. Some of the listed candidates had already been tested, 
serving as positive and negative controls in our assay. Additionally, 
we tested the plasmid pUC19cya without insert for secretion. 
We obtained 10 positives (amongst them the four positive controls), 
2 unclear, 11 negatives (including the 3 negative controls) out of 23 
tested constructs. Depicted in figure 11 are the positive, the unclear 
candidates and pUC19cya. Table 7 gives an overview of the results.   
 
 
 
 
 
 
 
 
 
Figure 11: Solid test of secretion 
on colonies. ipaB strain was 
transformed with chimeras, 
colonies grew overnight covered 
with a PVDF membrane. The 
membrane was used the next day 
to reveal the localization of the 
chimeras by using anti-Cya 
antibodies. Dot-shaped patterns 
show that constucts were not 
secreted, halo-shaped patterns 
demonstrate secretion of the 
construct into the medium.  
CPn0128 and CPn0091 are 
unclear; pUC19cya is a negative 
control; the rest is positive. 
CT862-61 - CPn0577 - 
CT862-87 - CPn0091 unclear 
CT035 NT CPn0928 + 
CT153 NT CPn0769 NT 
CT460 + CPn0176 - 
CT305 + CPn0927 NT 
CT576 - CPn0811 (- ctrl) - 
CCA00911 + CPn0887 (- ctrl) - 
CCA00743 - pUC19cya (- ctrl) - 
CPn0929 - CPn0489 (+ ctrl) + 
CPn1021 - CPn0483 (+ ctrl) + 
CPn0562 + CT868 (+ ctrl) + 
CPn0128 unclear CT867 (+ ctrl) + 
CPn0856 +   
Table 7: Secretion results for solid test. Tested 
were the candidates that were chosen due to 
eukaryotic-like domains in their sequence. 
Positive for secretion (+), negative for 
secretion (-), not tested (NT), signal too feeble 
to be interpreted (unclear).  
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3.3.2 Liquid Test 
The liquid test is more sensitive than the solid test but also more time consuming. To 
investigate whether our hybrid proteins are produced and secreted we fractionized 
exponentially growing liquid cultures of Shigella flexneri ipaB expressing the construct of 
interest into pellet and supernatant. The supernatant fraction was concentrated 25-fold 
compared to the pellet fraction. Hybrid proteins were subsequently subjected to a Western 
Blot probing them with antibodies against cyclase providing information about secretion. In 
order to exclude a signal in the supernatant fraction due to leakage or lysis of the cell, we also 
probed the membrane with antibodies against a cytosolic bacterial protein, cAMP receptor 
protein (CRP). To check whether the introduced construct hampered secretion we also 
checked the presence of IpaD, one of the Shigella flexneri proteins that is secreted by a TTS 
machinery in the supernatant. Candidates having a band for the chimera and IpaD in the 
supernatant (possibly also to a certain amount in the pellet) and a signal for CRP restricted to 
the pellet fraction were considered as positive for secretion.  
In order to test whether this secretion occured via a TTSS, the chimera was also introduced 
into Shigella flexneri mxiD possessing a totally impaired TTS machinery. If the chimera 
signal was only in the pellet and not in the supernatant, the candidate was considered as 
positive for TTS.  
Regarding the hits of proteins with a eukaryotic-like domain we chose to test all C. 
pneumoniae candidates, except CPn0483 and CPn0887 (which had already been tested 
previously). Additionally, we included CCA00911, CT878, CT876 and the candidates that 
had not been subjected to the solid test (CT035, CT153). This resulted in a list of 18 
candidates.  
Out of our hits we chose with the database „Effective“ we obtained 13 positive and 3 negative 
results regarding secretion (figure 12, table 8). Importantly, for all of them secretion in mxiD 
was negative, proving that it occured via a TTSS. Controls by IpaD and CRP validated the 
results. We could not determine the properties of secretion for two constructs (CPn0176 and 
CPn0577, not depicted in figure 12) since they were neither detected in the pellet nor in the  
supernatant of ipaB and mxiD. In conclusion, the results of these two from the solid test 
should be discarded.  
 
 
Results 
 
 45 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12: Liquid test of secretion on candidates chosen due to eukaryotic-like domains in their sequence. Liquid cultures of ipaB and 
mxiD expressing the indicated construct were franctionized into pellet (P) and supernatant (S) and run on a SDS-PAGE as described in 
Material and Methods. Supernatant fraction was concentrated 25-fold compared to pellet fraction. The membrane was probed with 
antibodies against Cya, IpaD and CRP.  CT = Chlamydia trachomatis, CPn = Chlamydophila pneumoniae 
 
 
 
 
 
 
 
 
By comparison of the valid results for the solid and the liquid test (table 9) we found a very 
good correlation. All candidates being positive in the solid test also revealed secretion in the 
liquid test. Only one candidate was negative in the solid and positive in the liquid test 
(CPn0929) confirming the higher sensitivity of the latter.  
Table 8: Secretion results for liquid test. Tested 
were the candidates that were chosen due to 
eukaryotic-like domains in their sequence. 
Positive for secretion (+), negative for secretion 
(-). 
CT867 + CPn0489 + 
CT868 + CPn0769 - 
CT035 + CPn1021 - 
CT153 + CPn0562 + 
CCA00911 + CPn0927 + 
CPn0811 - CPn0928 + 
CPn0128 + CPn0929 + 
CPn0091 + CPn0856 + 
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It is to mention that we can only exclude secretion by another secretory pathway for 
candidates we tested in the liquid test. The solid test was only performed with ipaB, not in the 
mxiD control. Still, the constructs are designed in the context of a TTS signal, thus the 
probability of secretion of the chimeras by another pathway remains very low. This is 
confirmed by the absence of signal in the mxiD supernatant we obtain in all our 13 positively 
tested constructs. 
 
 Solid Test Liquid Test  Solid Test Liquid Test 
CT862-61 - NT CPn0856 + + 
CT862-87 - NT CPn0091 unclear + 
CT035 NT + CPn0928 + + 
CT153 NT + CPn0489 + + 
CT460 + NT CPn0769 NT - 
CT305 + NT CPn0811 - - 
CT576 - NT CPn0927 NT + 
CT868 + + CPn0483 + NT 
CT867 + + CPn0887 - NT 
CPn0929 - + CCA00911 + + 
CPn1021 - - CCA00743 - - 
CPn0562 + + pUC19cya - NT 
CPn0128 unclear +    
 
 
3.4 Results for Glycogen Metabolism Candidates  
 
3.4.1 Liquid Test 
In a second set of the liquid test we tested all candidates chosen by their role in the glycogen 
metabolism (24 hits). 16/24 candidates were positive for secretion (figure 13, table 10), 
amongst which one failed the mxiD control (PcMalQ). It is therefore possible to confirm its 
secretion, but not to specify if this secretion occurs via a TTSS. Interestingly, we could detect 
that PUVGlgP2 was positive, whereas PUVGlgP1 does not even seem to be well expressed. 
Hence we assume that the nucleotide sequence for PUVGlgP2 is the right one for this protein. 
PUVGlgAΔ10 lacking the first 10 amino acids was not secreted neither (in contrast to 
PUVGlgA) proving again clearly the reliability of this assay.  
 
 
 
 
 
Table 9: 
Comparison of 
results for solid and 
liquid test of 
secretion. 
Candidates were 
chosen due to 
eukaryotic-like 
domains in their 
sequences. Positive 
for secretion (+), 
negative for 
secretion (-), not 
tested (NT), signal 
too feeble to be 
interpreted 
(unclear). 
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Table 10: Secretion results for liquid test. Tested were the candidates of Chlamydia trachomatis, Chlamydophila pneumoniae, 
Parachlamydia acanthamoeba and Candidatus Protochlamydia amoebophila proteins involved in glycogen metabolism. Positive for 
secretion (+), negative for secretion (-), not tested (NT), signal too feeble to be interpreted (unclear). 
 
 
 
All 21 candidates involved in the glycogen metabolism were also screened for TTS signals 
with EffectiveT3. Only three of the candidates had a predicted TTS signal (cut-off value at 
0.99): CTMalQ (T3 = 1), CPnGlgX (T3 = 0.99835) and PcGlgX (T3 = 0.9999).  
 Chlamydia 
trachomatis 
Chlamydophila 
pneumoniae 
Parachlamydia 
acanthamoeba 
Candidatus 
Protochlamydia 
amoebophila 
MalQ + + -  MalQ 
-  MalQBis 
+ (not clear if TTS) 
GlgA + + + GlgA 
-  GlgAΔ10 
NT 
GlgB + - + + 
GlgC - - + NT 
GlgP + + + GlgP2 
-  GlgP1 
NT 
GlgX + + unclear + 
Figure 13: Liquid test of secretion on candidates involved in glycogen metabolism. Liquid cultures of ipaB and mxiD expressing the 
indicated construct were franctionized into pellet (P) and supernatant (S) and run on a SDS-PAGE as described in Material and Methods. 
Supernatant fraction was concentrated 25-fold compared to pellet fraction. The membrane was probed with antibodies against Cya, IpaD 
and CRP.  CT = Chlamydia trachomatis, CPn = Chlamydophila pneumoniae, PUV = Parachlamydia acanthamoeba, Pc = Candidatus 
Protochlamydia amoebophila 
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3.4.2 Phylogenetic Analysis of Glycogen Metabolism Candidates 
We showed in the previous paragraph that chlamydial proteins engaged in the glycogen 
metabolism could have been secreted into the eukaryotic host. Here we will examine whether 
our phylogenetic analysis support a stable integration of the chlamydial genes encoding these 
proteins into the host genome.  
In collaboration with Prof. Thomas Rattei (University of Vienna, Austria) phylogenetic trees 
of Candidatus Protochlamydia amoebophila GlgA, GlgB, GlgC, GlgP, GlgX and MalQ were 
established (see appendix). Due to their large size only details are depicted. The tree for GlgA 
reveals a close grouping of Archaeplastida and Chlamydiae GlgA, especially to the 
environmental Chlamydiae Candidatus Protochlamydia amoebophila and Parachlamydia 
acanthamoeba. Similar results are obtained for GlgB. There is no specific relationship 
existing between archaeplastidal and chlamydial GlgC and GlgP according to our trees. 
“Environmental chlamydial” GlgX seems to be closely grouped with archaeplastidal GlgX. 
Interestingly, all Chlamydiales (except Simkaniaea) group together with a part of 
Archaeplastida in the tree for MalQ, but there is also another part of Archaeplastida which 
seems to have a MalQ more closely related to other bacteria.  
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4. Discussion 
 
4.1 Secretion Results of Computational Predictions 
 
4.1.1 Evaluation of Extraction of Eukaryotic-like Domains and Prediction of TTS Signal 
By focusing on eukaryotic-like domains that are enriched in the proteomes of pathogens and 
symbionts compared to non-pathogens we obtained a list of 38 proteins of C. caviae, C. 
trachomatis and C. pneumoniae. We chose to test 26 (two of them had a homolog being 
sufficiently conserved to assume the same secretion results) for secretion by a TTSS. This 
screen was performed in a heterologous TTSS of Shigella flexneri that has been shown to be 
functional for chlamydial effectors. Three of our candidates failed to be tested, for reasons of 
cloning difficulties or insufficient expression of the chimera (CPn0577, CPn0176, CPn1018). 
When transformed into the ipaB strain, chimeras positive for secretion were detected around 
the colony (solid test) or in the supernatant (liquid test). In the liquid test none of our positive 
chimeras was detected in the supernatant of TTS deficient mxiD, proving a secretion by the 
TTS machinery. We report the following observations of the identification of secreted 
chlamydial effectors (included two that were not tested, but whose amino termini are very 
conserved so that we made the assumption that they behave like the homologous protein that 
was tested):  
(i) 17/25 candidates are secreted by a TTSS, 8/25 were not secreted,  
(ii) 8/25 tested proteins had additionally a predicted TTS signal, under which 6/8 chimeras 
were indeed positive for secretion, 
(iii) all 7 candidates that reached a domain enrichment score of 10000 were secreted, 4/6 
proteins with a domain enrichment score of 4 (the threshold chosen for candidate selection) 
were secreted, 
(iv) when homologs of different chlamydial species were tested, they always showed 
consistent results. 
We can therefore assume that about 70% (17/25) of the chlamydial proteins that had an 
enrichment of a eukaryotic-like domain were secreted by a TTSS. We cannot exclude the 
secretion of the remaining 30% of candidates by another secretion pathway.  
LGT from a eukaryotic cell can occur to pathogenic/symbiontic and eventually also to non-
pathogenic organisms, but only be retained by pathogens/symbionts, giving rise to a domain 
enrichment score of 10000 (a domain enrichment score of 10000 excludes the presence of this 
domain in non-pathogens). However, a slight enrichment just above the cut-off of 3 also 
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seems sufficiently significant. It is indeed likely that eukaryotic-like domains being enriched 
in pathogens/symbionts strengthen their virulence or play at least a role within the process of 
communication between host cell and intruder. Since this communication often occurs via 
secretion of effectors into the host, the extraction of eukaryotic-like domains to pre-select 
putative effectors is a powerful tool. However, this tool only takes into account a subset of 
effectors and can thus only be additionally used.  
A method to obtain a more exhaustive list of candidates that are secreted by a TTSS would be 
based on a reliable prediction of a TTS signal. EffectiveT3 is a machine learning approach 
based on amino terminal features as frequencies of amino acids, amino acid properties and 
short combinations of them. This learning approach requires a huge data set of TTS effectors. 
Still, no extensive list of TTS effectors is available so far. By including the predictions of a 
putative TTS signal for our tested candidates we can state that the proposed secretion signal is 
rather too restrictive. 11/17 positively tested proteins were predicted to be negative. However, 
6/8 proteins that appeared as type III secreted in EffectiveT3 were indeed positive, indicating 
that this approach is very selective. The appearance of false negatives (or positives) can be 
due to wrong annotations of the translational start sites. It is therefore highly recommended to 
manually verify it before applying EffectiveT3. We took this into account and could only find 
one gene (CT862), where the translational start was ambiguous. Hence, we designed two 
different constructs, both revealing the same result (negative). We manually verified the 
remaining genes and found out that their translational starts were consistent with the ones of 
the source that was used for EffectiveT3. We can thus minimalize the bioinformatical bias of 
wrongly annotated translational starts or open reading frames.  
It has been suggested that a putative secretion signal partially (or fully) depends on the 
mRNA sequence. There are indications of the correctness of both theories, the mRNA signal 
and the peptide signal hypothesis. Consequently, this is an issue that still remains to be 
investigated in detail. However, we only looked at a putative TTS signal under the aspect of a 
strictly proteinaceous secretion signal. To date the idea that the mRNA sequence is partially 
also necessary for a proper secretion cannot be rejected totally. It might even be possible that 
the predominance of mRNA- or peptide-based sequences is dependent on the protein. Thus, it 
cannot be completely ruled out that the low number of predicted type III secreted proteins is 
due to an exclusive focus on a proteinaceous signal.   
 
4.1.2 Secreted Proteins, their Eukaryotic-like Domains and putative Function  
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Table 11 shows all tested candidates with their locus tag, description of the protein’s function 
indicated on GenBank, the eukaryotic-like domain with its Pfam name and its function as 
given on the Sanger Institute Pfam database.  Highlighted in blue are candidates that appeared 
to be negative and highlighted in yellow the positive ones. In the following we will give a 
short overview of each group of homologs (data about Pfam ID and domain function: CDD 
conserved protein domain database of NCBI).  
 
Chlamydophila 
pneumoniae 
Chlamydia 
trachomatis 
Chlamydophila 
caviae 
Pfam domain 
CPn0811 
low calcium response 
protein H 
CT576 
low calcium response 
protein H 
- PF07720 
Tetratricopeptide repeat 
- CT867 
hypothetical protein 
- PF02902 
Ulp1 protease family 
- CT868 
hypothetical protein 
- PF02902 
Ulp1 protease family 
CPn0128 
biotin protein ligase 
CT035 
biotin protein ligase 
- PF09825 
Biotin-protein ligase 
- CT153 
MAC/perforin family 
protein 
- PF01823 
MACPF protein superfamily 
CPn0091 
V-type ATP synthase 
subunit I 
CT305 
V-type ATP synthase 
subunit I 
- PF01496 
V-type ATPase 
CPn0489 
 hypothetical protein 
CT386 
metal dependent hydrolase 
- PF03690 
Uncharacterised protein 
family (UPF0160) 
- CT460 
SWIB (YM74) complex 
protein 
- PF02201 
SWIB/MDM2 domain  
 
CPn0769 
DNA topoisomerase I/SWI 
domain fusion protein 
CT643 
DNA topoisomerase I/SWI 
domain fusion protein 
- PF02201 
SWIB/MDM2 domain  
 
CPn1021 
low calcium response 
protein H 
CT862 
type III secretion chaperone 
- PF07720 
Tetratricopeptide repeat 
CPn0562 
CHLPS 43 kDa protein 
homolog_1 
- - PF05677 
Domain of unknown 
function (DUF) 
CPn0927 
CHLPS 43 kDa protein 
homolog_2 
- - PF05677 
Domain of unknown 
function (DUF) 
CPn0928 
CHLPS 43 kDa protein 
homolog_3 
- - PF05677 
Domain of unknown 
function (DUF) 
CPn0929 
CHLPS 43 kDa protein 
homolog_4 
- - PF05677 
Domain of unknown 
function (DUF) 
CPn0856 
UTP-glucose-1-phosphate 
uridylyltransferase 
- CCA00911 
UTP-glucose-1-phosphate 
uridylyltransferase 
PF01704 
UTP-glucose-1-phosphate 
uridylyltransferase 
CPn0483 
hypothetical protein 
- - PF10275 
Peptidase C65 Otubain 
- - CCA00743 
hypothetical protein 
PF08123 
Histone methylation protein 
DOT1  
CPn0887 
CHLTR phosphoprotein 
- - PF07720 
Tetratricopeptide repeat 
Table 11: Tested proteins and eukaryotic-like domains. Homologs are in the same line with their eukaryotic-like domain. Highlighted in 
yellow: positive for secretion. Highlighted in blue: negative for secretion.   
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Proteins that are secreted: 
 
CT867 – CT868 
CT867 and CT868 are two adjacent homologous ORFs. They possess deubiquinating and 
deneddylating activity (Misaghi et al., 2006). Ubiquitination and neddylation only occur in 
eukaryotes, therefore our results that these deubiquitinating and deneddylating proteins are 
secreted support previous findings of their activity. Interestingly, homologs of these proteins 
have been found only in C. trachomatis and C. muridarum. Their eukaryotic-like domain 
belongs to the Ulp1 protease family containing the catalytic triad Cys-His-Asn.   
 
CPn0128 – CT035 
The attachment of biotin to requiring proteins is triggered by biotin ligase proteins, in 
eukaryotes as well as in prokaryotes. It has been shown that biotin is a cofactor in the 
metabolism of fatty acids, leucine and interestingly, also in gluconeogenesis (Pacheco-
Alvarez et al., 2002). According to Belland et al. (Belland et al., 2003) CT035 belongs to the 
immediate early expressed genes in the infection cycle of C. trachomatis. Translocation of 
this biotin ligase protein into the host cell might trigger the production of glucose or fatty 
acids in the cytoplasm, which could then be available for the chlamydial pathogen. This 
would be an intriguing subject for further investigation. Interestingly, the enriched eukaryotic-
like domain is annotated as the domain that is found N-terminal of the catalytic site of the 
biotin protein ligase.  
 
CT153 
The eukaryotic-like domain belongs to the MAC/perforin superfamily. Their members are 
proteins that oligomerize from monomers to oligomeric membrane-spanning pores, exhibiting 
cytolytic activity in vitro. Taylor et al. (Taylor et al., 2010) showed that CT153 is already 
present in EBs and is proteolytically processed immediately following infection, suggesting a 
role in the very early pathogen/host cell interactions. They propose that it is an important 
factor for the acquisition or modification of host cell derived lipids. The mechanism by which 
CT153 access the host cell cytosol was not discussed, our results strongly argue for a TTS 
mechanism.  
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CPn0091 – CT305 
Both proteins were positive in our test of secretion. They are annotated as V-type ATP 
synthase subunit I which is part of the membrane proton channel due to their enrichment of 
the eukaryotic-like domain “V-type ATPase”. ATP synthases in general have the function to 
produce ATP from ADP in the presence of a proton gradient across a membrane. It would be 
interesting to investigate whether this subunit is the only one to be secreted or if the remaining 
parts which are clustered with subunit I in the genome are also effectors. Chlamydia have the 
capacity to take up host cell derived ATP (Tjaden et al., 1999; Hatch et al., 1982). 
Consequently, it would be interesting to investigate whether Chlamydia enhance the host 
cell’s ATP production in order to transport this source of energy into the bacterial cytosol, and 
which proton gradient is used to do so.   
 
CPn0489 - CT386 
CPn0489 is annotated as hypothetical protein, whereas the predicted function for CT386 is 
that of a metal dependent hydrolase. Its composite domain can be found in several bacterial 
and fungal enzymes, e.g. in the virulence factor urease of Helicobacter pylori (Davies et al., 
2002) . More functional studies have to be done on CPn0489 and CT386 before suggesting a 
role of the secreted proteins in the host cell. Their eukaryotic-like domain is of an 
uncharacterized protein family (UPF0160) containing a large number of metal binding 
residues. The patterns suggest a phosphoesterase function.  
 
CT460 
The eukaryotic-like SWIB (YM74) domain is a conserved region of the mammal protein 
BAF60b, which plays a role in chromatin remodelling. It has been suggested by Bennett-
Lovsey et al. (Lovsey et al., 2002) that the SWIB domain in Chlamydia is derived from 
eukaryotes and acts on the condensation and decondensation of the chlamydial genome during 
its developmental cycle. They also gave evidence for the homology of the SWIB protein 
domain to MDM2, a eukaryotic inhibitor of the tumour suppressor p53. p53 leads in 
cooperation with NF-B to apoptosis of the cell (Ryan et al., 2000). Further studies have to be 
conducted in order to specify the function that a secreted CT460 could fulfill within the host 
cell. 
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CPn0562 – CPn0927 – CPn0928 – CPn0929 
These four proteins are homologs with unknown function. They all possess the same domain 
and belong to the DUF818 (domain of unknown function) superfamily. No homologs are 
present in the Chlamydia trachomatis genome. Strikingly, all four homologs are positive and 
possess different amino termini, indicating that they are bona fide effectors. 
 
CPn0856 – CCA00911 
These homologs are annotated as UTP-glucose-1-phosphate uridylyltransferase (PF01704), 
which is another name for UDP-glucose pyrophosphorylase. Its function is described above 
(1.5.2.1). Remarkably, UDP-glucose is a eukaryotic metabolite, hence secretion into the 
eukaryotic host cell is very likely to occur. This is supported by our secretion results. 
 
CPn0483 
Unpublished data of Subtil et al. give evidence for a secretion of this protein at the entry step 
of C. pneumoniae. CPn0483 interacts with NDP52. Mammalian cells ubiquitinate bacterial 
intruders for distruction by autophagy. Ivanov and Roy (Ivanov and Roy, 2009) show that 
NDP52 binds to these ubiquinated bacteria and facilitates their degradation. It is thus 
conceivable that CPn0483 hampers this process and plays a role in the bacterial evasion of the 
host cell’s response. Its eukaryotic-like domain is the peptidase C65 Otubin, a highly specific 
ubiquitin isopeptidase that removes ubiquitin from proteins.  
 
Proteins that are not secreted: 
 
CPn0811 – CT576 
The homologous pair CPn0811 and CT576 are both annotated as “low calcium response 
protein H (LcrH)” possessing a eukaryotic-like domain that is characterized by 
tetratricopeptide repeats. These repeats are generally found in chaperones. It has been shown 
that CPn0811 functions as a chaperone for the TTSS, which is expressed from the middle to 
late stages of the chlamydial developmental cycle (Faludi et al., 2009). Both were negative for 
secretion. As mentioned above, chaperones are not secreted and are released from the 
substrate-chaperone complex by ATPase activity. The description about the function of both 
proteins fits well with our findings. 
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CPn0769 – CT643 
Both proteins have the predicted function of a DNA topoisomerase I/SWI domain fusion 
protein. This family of proteins catalyzes the ATP-dependent breakage of single-stranded 
DNA followed by passage and rejoining and is therefore part of the DNA damage response 
(Bugreev and Nevinsky, 2009). This process is likely to take place within the bacterium, 
which supports our negative secretion results. Interestingly, they possess the previously 
mentioned SWIB/MDM2 domain, which is also present in a positive candidate (CT460). 
 
CPn1021 – CT862 
Slepenkin et al. (2005) showed that CPn1021 interacts with chlamydial CopN, a TTSS 
effector, suggesting that CPn1021 functions as a chaperone. Additionally, Fields and 
Hackstadt (Fields and Hackstadt, 2000) proposed the same function and interaction for CT862 
in Chlamydia trachomatis. Both homologs possess the domain including tetratricopeptide 
repeats (mentioned above) found in chaperones. This would be consistent with our findings.  
 
CPn0887 
CPn0887 is annotated as a CHLTR phosphoprotein (NCBI). Phosphoproteins are proteins that 
are modified post-translationally by phosphorylation. CPn0887 has homologs in C. caviae 
and C. trachomatis, both of which possess no enrichment of a eukaryotic-like domain. 
CPn0887 reveals an enrichment of tetratricopeptide repeats usually found in chaperones.  
 
CCA00743 
CCA00743 is a hypothetical protein, no reports about functional studies are available. A 
BLAST-research did not reveal any homology to bacterial proteins except for Chlamydophila. 
Its eukaryotic-like domain is annotated as Histone methylation protein DOT1 regulating gene 
expression by methylating histone H3. 
 
In the following we will concentrate on the eukaryotic-like domains that were present in our 
candidates. Table 12 gives the numbers of positive and negative results we obtained for each 
domain.  
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Domain Positive Negative Domain Positive Negative 
PF01704 2 0 PF08123 0 1 
PF07720 0 5 PF05677 4 0 
PF01496 1 0 PF09825 2 0 
PF10275 1 0 PF03690 2 0 
PF02201 1 2 PF02902 2 0 
PF01823 1 0 PF01496 1 0 
Table 12: Eukaryotic-like domains present in tested candidates. Given are the numbers of positive and negative results obtained in the 
secretion test.  
 
 
Interestingly there was one domain (PF02201), which was present in one secreted and in two 
not secreted candidates. The remaining domains were consistent in their presence in either 
secreted or non-secreted proteins.  
 
4.2 Tripartite Symbiosis and Enzymes Engaged in Glycogen Metabolism 
 
4.2.1 Secretion Results of Enzymes Engaged in Glycogen Metabolism  
The heterologous secretion test revealed that GlgA, GlgB, GlgC and GlgP but not MalQ were 
secreted by P. acanthamoeba (table 13). We cannot make any statement about GlgX, since 
the secretion results were not clear. Not all of these candidates were tested for Candidatus 
Protochlamydia amoebophila. However, the tested ones (GlgB, GlgX and MalQ) were all 
positive. What could be the function of these secreted proteins during infection by 
Chlamydiales in the host cell?  
 
4.2.2 Putative Role of Enzymes in Chlamydiae Infected Cells 
In the beginning of an infection GlgC can promote the synthesis of ADP-glucose in presence 
of a high cytosolic ATP level (Ballicora et al., 2003). ADP-glucose is neither recognized nor 
used by the host cell. GlgA and GlgB would increase the glycogen production in the host cell 
as long as the ATP level remains high. Upon decrease of the host cell’s energy stock 
(decrease of the ratio ATP to Pi) degradation of glycogen to subunits occurs by the function 
of GlgX, which releases glucose-1-P and maltotetraose (Ball et al., 2011). Interestingly, 
maltotetraose is not a eukaryotic metabolite and could therefore represent a substrate for 
import into the chlamydial invader. However, we cannot exclude that host enzymes are able 
to metabolize maltotetraose into smaller molecules which could also be substrates for import.  
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Substrate Metabolized by Secreted 
(Pa/CP) 
Phylogenetics 
Glucose-1-P GlgC +/? - 
ADP-glucose GlgA +/? ++ 
Linear glucans GlgB +/+ ++ 
Glycogen GlgP +/? - 
Phosphorylase limit dextrin GlgX ?/+ ++ 
Debranched glucans MalQ -/+ + 
Table 13: Secretion results and phylogenetic relationship between chlamydial protein and archaeplastidal homolog. Given is the substrate of 
the respective enzyme (“metabolized by”), the secretion results for P. acanthamoeba (Pa) and C. P. amoebophila (CP), (+) positive for 
secretion, (-) negative for secretion, (?) unclear or not tested; Phylogenetic analysis: (++) very close grouping between chlamydial and 
archaeplastidal homolog, (+) grouping between chlamydial and archaeplastidal homolog, (-) no grouping between chlamydial and 
archaeplastidal homolog.  
 
Further recession and break-down of the sugar chain occurs by secretion of MalQ (not for P. 
acanthamoeba). Manipulation of the host cell’s glycogen pool would be an effective way to 
stock all the ATP which is available at the beginning of the infection in metabolites that 
cannot be used by the host cell. Even when the energy level of the host cytosol becomes 
critically low, the parasite would still be provided with carbon. Little is known about suitable 
transporters in the inclusion and chlamydial membranes to bring these metabolites to the 
parasite. However, their presence would be a prerequisite for this scenario. 
 
4.2.3 Probability of LGT from Chlamydiae to Host Cell 
Our phylogenetic analysis suggests that GlgA, GlgB, GlgX and eventually MalQ could have 
been transferred from Chlamydiales (especially the environmental Chlamydiae) to the 
archaeplastidal ancestor by LGT. This is not the case for GlgC and GlgP. We proposed the 
theory that ADP-glucose was contributed to the host by the cyanobiont. Hence, the side of 
ADP-glucose production would not be in the eukaryotic host cell. This would explain that the 
transfer of GlgC was not necessary. The host would nevertheless need enzymes to metabolize 
this product. LGT of GlgA and GlgB would ensure the synthesis of glycogen. Catabolic 
enzymes such as GlgX and MalQ would deliver smaller products of degradation. Still, 
eukaryotic cells possess their own glycogen metabolism. These second “newly-obtained” 
enzymes engaged in the glycogen metabolism are somehow auxiliary, being consequently 
prone to genetic changes since they only function as an additional set for glycogen 
production. It is not the today’s glycogen metabolism engaged enzymes in plants that are 
related to chlamydial genes, but the enzymes in plants engaged in the starch metabolism (see 
Ball and Morell, 2003 for a review of starch metabolism).  
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We showed here that it is possible that Chlamydiae secreted enzymes engaged in the glycogen 
metabolism into the host cell. These enzymes might have rescued the host as a secondary 
effect, since they gave the host cell the opportunity to acquire energy out of another source: 
the cyanobiont. Subsequently, specific genes of these enzymes could have been transferred by 
LGT to the host cell. We can support this hypothesis by close relationships of chlamydial 
GlgA, GlgB, GlgX and MalQ to archaeplastidal homologs. At the beginning they could have 
fulfilled an auxiliary function in the eukaryotic glycogen synthesis, evolving finally to 
enzymes necessary for starch production. Stephen Ball’s analysis, which we repeated, 
suggested that chlamydial GlgA is closely related to archaeplastidal soluble starch synthase 
III/IV according to phylogenetic trees. Archaeplastidal isoamylases (starch debranching 
enzymes) are also likely to be derived from chlamydial GlgX (Stephen Ball, unpublished 
data, and our own analysis). The archaeplastidal homolog to GlgB is annotated as either 
glycogen branching enzyme or starch branching enzyme. The closest archaeplastidal 
homologs of MalQ are amylomaltose, also called 4-α-glucanotransferase. 
So far, the hypothesis of a tripartite symbiosis between a heterotrophic organism, the 
cyanobiont and a chlamydial parasite is a conceivable scenario, which we strengthened with 
our demonstration that chlamydial enzymes possess functional TTS signals. However, some 
links are still missing. We introduced cyanobacterial ADP-glucose as the key substrate that 
would enforce a tripartite symbiosis. However, it is not known whether ADP-glucose could 
have been transported into the host cytosol in such an early stage of “preliminary 
endosymbiosis”. Not a lot is known about chlamydial enzymes engaged in glycogen synthesis 
and their function in the eukaryotic cytosol. A very important aspect would be to track the 
way of the glycogen pathway in Chlamydiae and the host cell upon an infection. For example, 
are there transporters that can bring the catabolic products of the glycogen metabolism from 
the cytosol into the bacteria? Is it hence indisputable that secretion of these enzymes takes 
place, to the profit of the parasite? The unquestionably most important question is however: 
can we be sure that since over one billion years (the time when this scenario was proposed to 
take place) the genome of our tested Chlamydiae stayed sufficiently conserved to make 
predictions about their characteristics at that time? The proposed hypothesis is an intriguing 
subject, which deserves attention and more profound research.  
 
4.3 Secretion Results of C. trachomatis and C. pneumoniae “Glycogen-Enzymes”  
It has been reported that glycogen particels can be detected upon infection with C. 
trachomatis but not with C. pneumoniae. These glycogen particles are visible in the inclusion, 
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in EBs and RBs (Chiappino et al., 1995). They appear at 20-30 hours post-infection and peak 
at 30-60 hours post-infection (Iliffe-Lee and McClarty, 2000). It is typically assumed that the 
particles in the inclusion lumen are due to ruptured bacteria, and that these particles are 
originally synthesized within the bacteria. We will here briefly discuss the secretion results 
we obtained for the C. trachomatis and C. pneumoniae enzymes engaged in the gycogen 
metabolism. Both, C. trachomatis and C. pneumoniae possess a full set of homologs for 
GlgA, GlgB, GlgC, GlgP, GlgX and MalQ, even though glycogen has only been detected in 
C. trachomatis. GlgC seems not to be secreted in neither C. trachomatis nor C. pneumoniae. 
Interestingly, GlgA is secreted in both, GlgB only in C. trachomatis. We here ask the 
unsolved question why GlgA, which uses ADP-glucose as substrate, is secreted. ADP-glucose 
is not available in the hosts of C. trachomatis and C. pneumoniae. In a previous test we 
demonstrated that CPn0856, a UDP-glucose-pyrophosphorylase producing UDP-glucose as a 
substrate is secreted. Is it possible that GlgA of C. trachomatis and C. pneumoniae are able to 
use mammal UDP-glucose as a substrate? This has never been tested. It is to mention that 
these Chlamydiales are much younger in their evolution than environmental Chlamydiae. 
Their GlgA homologs could possibly have evolved as an adaptation to use UDP-glucose as 
substrate, which is indeed produced by their host cell, eventually also due to secretion of the 
chlamydial UDP-glucose pyrophosphorylase. GlgB is only secreted by C. trachomatis. 
Glycogen particles are only found in C. trachomatis. Is it possible that the detected glycogen 
particles in the inclusion are no artefact of lysed bacteria, but that glycogen is actually stored 
in the inclusion of C. trachomatis? Does in contrast C. pneumoniae synthesize unbranched 
glycogen in the inclusion, which have never been detected? Or does another pathway exist for 
further processing of these elongated unbranched sugar chains in C. pneumoniae?  
Both pathogens secrete the catabolic enzymes necessary for glycogen break-down (GlgP, 
GlgX, MalQ). Glycogen is a product of their eukaryotic host, allowing the intruders to 
parasite this energy source. Again, this theory is only coherent when transporters for the 
break-down products into the bacteria are present.  
We asked here a lot of unsolved questions, which we will partially try to further examine in 
the future.  
 
4.4 Efficiency of Heterologous Secretion Test  
Due to the lack of genetic means to manipulate Chlamydiae the heterologous screen is a very 
valuable tool to test whether proteins are or are not secreted by a type III machinery. Positive 
and negative controls that were included in this and in previous tests proved its reliability. 
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However, this screen is performed on chimeras containing the amino terminus of the protein 
of interest. As it has already been mentioned, there have been hints for the existance of a 
second signal, the CBD (chaperone-binding domain). For several full-length effectors it has 
been shown that the association with a specific chaperone is important for an efficient 
secretion. In our clones the CBD is excluded. Additionally, it is not likely that all homologs of 
chlamydial chaperones are encoded in the Shigella genome. Even though we can suppose that 
our constructs are too short to be obligatory unfolded for functional translocation, thereby 
bypassing the need for CBD, we do not know whether the amino terminal secretion signal is 
sufficient in all proteins.  
Additionally, we cannot exclude the occurence of false positives. However, Subtil et al. 
(Subtil et al., 2005) showed that this occurence is below 5%.  
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5. Summary 
 
Chlamydiae are obligate intracellular parasites infecting a broad spectrum of organisms such 
as animals, insects and amoeba. These gram-negative bacteria are worldwide a major cause of 
preventable blindness and infertility in humans. Upon infection of a eukaryotic host cell 
Chlamydiae multiply within a parasitophorous compartment termed inclusion, where they 
also undergo conversion from an infectious, metabolically rather inert form to a non-
infectious, metabolically active form. Both forms possess a type III secretion system in order 
to translocate potentially toxic effector proteins to targets within the host cell.  
No genetic tools to manipulate Chlamydiae are available so far due to their obligate 
intracellular lifestyle, hampering the examination of putative secreted effectors. The 
identification of type III secreted proteins is additionally complicated by the fact that the 
molecular recognition of effectors by a type III machinery is still elusive. However, various 
experiments suggest a signal in the 20 amino terminal amino acids of the effectors.  
We made use of the already published approach of testing putative chlamydial effectors in a 
heterologous type III secretion system of Shigella flexneri in order to identify novel type III 
secreted proteins. For this purpose we designed chimeras consisting out of the 20 amino 
terminal amino acids of a candidate protein fused to a reporter, the calmodulin-dependent 
adenylate cyclase (Cya) of Bordetella pertussis. These chimeras were expressed in different 
strains of Shigella flexneri. By applying an antibody against Cya we could localize the 
chimeras and determine their characteristics of secretion.  
In order to create a list of candidates that we subsequently subjected to this secretion test we 
made use of the finding that many effectors have been shown to contain protein domain 
signatures that are typically found in eukaryotes. The software “Effective” gave us 
precalculated lists for proteins enriched in these “eukaryotic-like domains” in the proteomes 
of Chlamydia trachomatis, Chlamydophila pneumoniae and Chlamydophila caviae. With the 
previously mentioned heterologous secretion test we demonstrated that 17/25 chosen 
candidates were positive for type III secretion. The software “Effective” is thus a very useful 
approach, but it can only be used additionally, since other proteins we tested as positive were 
not listed by this software.   
Additionally, we tested an assortment of proteins of environmental Chlamydiae engaged in 
glycogen metabolism for secretion. This assortment was chosen regarding the function these 
enzymes could have fulfilled to stabilize the formation of endosymbiosis between a 
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cyanobiont and a heterotrophic organism. We showed that almost all of these enzymes are 
indeed secreted and that some of them seem to be closest related to plant homologs, 
strengthening the hypothesis of an indispensable role of Chlamydiae in the early history of 
development of today’s plants.  
We further examined if these enzymes have different secretion characteristics in C. 
trachomatis and C. pneumoniae, knowing that only C. trachomatis accumulates glycogen. We 
could state differences here and gave suggestions for further thoughts.  
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7. Appendix 
 
7.1 Sequences of the inserts cloned in the pUC19cya vector 
Upstream of the initiation codon, the sequences provide a HindIII restriction site (if not BsaI, 
marked with an asterisk), a stop codon terminating translation from the α-Galactosidase 
sequence in pUC19, and about 10 nucleotides as spacer between this stop codon and the 
initiation codon of the gene of interest. The stop codon was spared when present in this spacer 
sequence. The constructs include approximately the first 20-30 codons of the gene of interest, 
followed by a XbaI site (if not BsaI, marked with an asterisk), for cloning into the pUC19cya 
vector. If site of initiation could not be unambigously identified, two constructs were designed 
(marked with a plus). Restriction sites are underlined. 
 
Parachlamydia acanthamoebae: 
 
GlgA 
AAGCTTGTAATAGTTTTGTTTTTATGCATATTATTCATATCGCAGCAGAACTTGCA
CCACTTGCCAAAGTCGGCGGCCTTGCAGATGTTGTTCTCGGACTCTCTCGTGAACT
ATCTAGA 
 
GlgAΔ10 
AAGCTTGTAATAGTTTTGTTTTTATGGCACCACTTGCCAAAGTCGGCGGCCTTGCA
GATGTTGTTCTCGGACTCTCTCGTGAACTATCTAGA 
 
 
GlgC 
AAGCTTGTAATAGTTTTGTTTTTATGTCTTTGTTAACCACACCCCATGTAAAAACG
ACTCCACTAACACAAACAATCAATTTGCACACACACCGCACAGATCGGGTTGCAT
CCTCTAGA 
 
MalQ+ 
AAGCTTGTAATAGTTTTGTTTTTATGACAAACTTTTTTCTGCAGCAATTGCTTGAA
AATCCTGATAGCCTTCCACACCATGGAATTTGCCTTCCCATTTTCTCTTTACACTC
CTCTAGA 
 
MalQbis+ 
AGTCAAGCTTGTAATTACTGAGGAATGGTAACGATGACAAACTTTTTTCTGCAGC
AATTGCTTGAAAATCCTGATAGCCTTCCACACCATGGAATTTGCCTTCCCATTTTC
TCTAGAGACT 
 
GlgP1 
AAGCTTGTAATAGTTTTGTTTTTATGAGTACATTAGCGGATTTGCCCTCTCAGGAG
AAGGTTAGTCAGGATAAATCGATTCGTACTGGATTAAGTGTTGAATCTTTAAAAA
AATCTAGA 
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GlgP2 
AAGCTTGTAATAGTTTTGTTTTTATGACGCAACCAGCACCCGATCTTGATTATCAA
GCAGAAATGTTAGCTGCTAAAACAAAGCATTATTTGATTACAACCATGGGGCGTA
TCTCTAGA 
 
GlgX 
AAGCTTCTAATTCCTTTAATTTAGGCAAATACGTGTCAGAGCTTCAGTCTTTTCAA
GTAGAAAAAGGATCCCCTCTTAACTTAGGTATCTTTGGTGATTGCGGCGGAATCA
ATTTTTCCCTTTCTAGA 
 
GlgB 
AAGCTTGTAATAGTTTTGTTTTTATGGAAACGCACACATCTCCCCTTACCCACACT
CAATTTGATTCATTACTTGCTGGAGAAGCCTTTGACCCCCACCAATTTTTAGGACT
ATCTAGA 
 
Candidatus Protochlamydia amoebophila 
 
GlgX 
AAGCTTGTAATAGTTTTGTTTTTATGAATATACAAATAACACCTGGATCCCCCTTT
CCTTTTGGTGCAAATATACAAGAAGGAAAGGTTAATTTTGCTCTTTATGCTAAAA
ATTCTAGA 
 
MalQ 
AAGCTTGTAATAGAAGCGAAAATTTGGTCCGATGCTCTCAATCAAGGAAATGTTC
CGTATATTACAGAAATTACCAATACTCCTCCTGCACCTCCATTTGGTTATCAAAGA
TGATAGATCCTACTTTCTTACTTCATTCTCTTGCGGCTAAACAGTGGGAGCGAATC
GGTATCAAGCACCATCATGGAATCAATGTTCCTTCTAGA 
 
GlgB 
AAGCTTGTAATAGTTTTGTTTTTATGATGACTATGCAACAGACTGAATTTGACTCT
CAATTTAATGAACACATTTATCGTATCGTTCATGTTGTTCATCACCAACCTCATGC
TTCTAGA 
 
Chlamydia trachomatis  
 
CT862-61+ 
AAGCTTATAGGCCATCTCCAAGAAGTGTCTCAATGCCACCAAGCAAGATCCAATG
TCTTGAAACTTTTAAAAGAACTTATGGACACCTTTATCTACAACATGCGTCCCTAA
TGCGTCATTTAGCCTATCTACTCGATAAAATTGCTCGCTCTTACCATCATATGTGT
CCGCTTCCCGATAATATGTCTAGA 
 
CT862-87+ 
AAGCTTATAGAGGACACCTTTATCTACAACATGCGTCCCTAATGCGTCATTTAGC
CTATCTACTCGATAAAATTGCTCGCTCTTACCATCATATGTGTCCGCTTCCCGATA
ATATGTCTAGA 
 
CT035 
AAGCTTATAGAGGCAAAGAGATGAAGCGTATCTTAGTGTATTCGGATAGAGGAG
TTTCTCCTTACTATTTGCGCCATACTGTTCGCTGGTTGAAGCAGGTAGCTGCTCCA
TTCCAGTCTAGA 
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CT153 
AAGCTTGTTCCTTCCATTATAGGGTGTCAATCACTGTCCAGCCCGGAGAGTTTTTA
ATGACTAAGCCTTCTTTCTTATACGTTATTCAACCTTTTTCCGTATTTAATCCACGA
TTAGGACGTTTCTCTTCTAGA 
 
CT460 
AAGCTTCTTTTCTTATCATCTTCTTTAACTAGGAGTCATCCATGAGTCAAAATAAG
AACTCTGCTTTCATGCAGCCTGTGAACGTATCCGCTGATTTAGCTGCCATCGTTGG
TTCTAGA 
 
CT305 
AAGCTTTTAGGAGTAGTCTGCATGCGCGTAGATGTGGATAAATATCTATTTATTG
GACGTGAGAAGTCTGAATTTTTCTCTGCATGTCGAGAGATTGGGGCTGTCGAATT
TTCTAGA 
 
CT576 
AAGCTTTTAGGAATTATCGCGATGAGCACTCCATCTTCTAATAATTCTAAAAAAC
CTTCGGCCTCTTTTAATAAAAAATCACGTAGCCGCTTGTCTAGA 
 
MalQ 
AAGCTTGTAATAGTTTTGTTTTTATGCCGTCATTATCCCAATCCCGACGTATCATC
CAGCAATCTTCCATTCGAAAGATTTGGAATCAGATAGATACTTCTCCTAAGCATG
GCTCTAGA 
 
GlgA 
AAGCTTGTAATAGTTTTGTTTTTATGAAAATTATTCACACAGCTATCGAATTTGCT
CCGGTAATCAAAGCCGGAGGCCTGGGAGACGCGCTATACGGACTAGCATCTAGA 
 
GlgB 
AAGCTTGTAATAGTTTTGTTTTTATGGATCCTTTTTTCTTAAATACTCAACACGTG
GAACTTCTCGTTTCTGGTAAACAGAGCAGTCCACAAGATCTTTTGGGAATTGTTTC
TTCTAGA 
 
GlgC 
AAGCTTGTAATAGTTTTGTTTTTATGGCTGGTAGACGGACGAAAGAAGAGCAGAT
CAATCGAAAACGATCGCATTTCTATCGAGATAACGTAGGAGTTATTGTCTTATGC
GGATCTAGA 
 
GlgP 
AAGCTTGTAATAGTTTTGTTTTTATGTATTTCGATCGGACAAAGATCAATGTTGAA
TCTATGAAGCAAGCTATCCTCGAAAGGGTATATTGTGGGGTAGTCCAGACTCCTC
AATCTAGA 
 
GlgX 
AAGCTTGTAATAGTTTTGTTTTTATGGAATCTTTGTCTGTTCGTTCCACTATCCCTT
TACCTCTAGGAGCCAAAAAGCTCTCCGCTGATCGCTACCGTTTTTCTCTATTTTCT
TCTAGA 
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Chlamydophila caviae 
 
CCA00911 
AAGCTTATCTAACATCAAGAGATAGGAACGCAAGGCTAACTGTAATGACTGACTC
TGTAACCTTTCCTTCTGCTGTGGAAATGTCTTCACTAACAGAAAAACTCAAGTCTA
TTAATCAAGAGCATTCTAGA 
 
CCA00743 
AAGCTTATAGACCGATTTACAAGTTGAAGAAGATATATTTGCTATAGAAGATGTC
GTATTTCAACCGCCTAAAGAGCTCCGTAATTAAAAAGTCTTCATTCTTACATATAT
TGCGAGTAGGAATGCATTCTAGA 
 
Chlamydophila pneumoniae  
 
CPn0929 
AAGCTTATAGTTAAATTTTATAGGAAAAGTTCATGGCTCCAATTCACGGAAGTAA
TGCGTTTGTTGAGGATATTTTACATTCCCACCCTTCTCCACAAGCGACTTATTTTTC
TAGA 
 
CPn1021 
AAGCTTATAGAGGACACCTTCATTTACAACCTACGCCCCTAATGTCACATTTAAA
TTATTTACTAGAAAAAATCGCTGCATCTTCCAAGGAAGACTTCCCTTTCCCAGATG
ATTCTAGA 
 
CPn0562 
AAGCTTATAGACTACATTCTGCATGAAATTATAAGGTAATAATGTCAATAGCTAT
TGCAAGGGAACAATACGCAGCTATATTGGATATGCATCCTAAACCTTCGATCGCC
ATGTCTAGA 
 
CPn0128 
AAGCTTATAGCGCTTTTCTGTTCGAGAGGAAAATAAGAAGATAGGGGAAGAATG
TTAAGGAATCAGGTACTTGTTTACTGTAGTGAGGGTGTTTCTCCTTATTATTTACG
GCATACGATACGTTCTAGA 
 
CPn0856 
AAGCTTGGATCAAGAGATAGGAACGTAAGGCTAACTGTAATGACTGAATCGGTA
TATTCGCCCTCTGCTATGCATGTAAACTCTCTAGCAGATAAGCTCAAAGCCATATC
TAGA 
 
CPn0091 
AAGCTTAAGATAGAACTCCGGAAAGCAAGGGGGGATGAGTGCGTTTAAATATAC
ATAAGTATCTCTTTATAGGACGCAATAAGGCGGATTTTTTTTCTGCAAGTAGAGA
GCTTGGTTCTAGA 
 
CPn0928 
AAGCTTAGAGACGTAAGGATTTCGCATTCACTCTTTTGAATCTTTCAAACAGGTCT
GATATTTTGTCAGGAATATTTTCAAATCCTCATCCAGTTTCCTATTTTTCGTCATCT
AGA 
 
CPn0489 
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AAGCTTGTTACAATGGAGGATTGGCTAAGGAGGATAGTAGGTATGCAGATTCCA
AGAAGCATTGGTACTCACGATGGTTCTTTCCATGCGGATGAGGTCACAGCGTGTT
CTAGA 
 
CPn0811 
AAGCTTTTAGGAATTAGATCGATGAGCAAGCCCTCTCCTCGTAATGCCAATCAAC
CTCAAAAACCTTCAGCCTCTTTCAATAAAAAAACGCGAAGCCGTCTATCTAGA 
 
CPn0927* 
AAGCTTCTTTTGTTCTCTTTATACTCTGTGTACCTAAAATTTAGGACTCTTGTATGA
TCCCATCCCCTACCCCAATAAACTTTCGTGATGATACGATTCTAGAGACGGATCC
AAAGCCGTCTAGTGAGACC 
 
CPn0577 
AAGCTTGTAGTCAGGTCTCTTCTTACCACCTTTACTAGGAGTCACCAATGAGTCAA
AAAAATAAAAACTCTGCTTTTATGCATCCCGTGAATATTTCCACAGATTTAGCAG
TTATAGTTGGCAAGGGACCTATGTCTAGA 
 
CPn0176* 
GGTCTCTAGCTAGGCGAAGTTAAGGAAGCTCTGAAACGATGATGATCCTATGGAT
GAATCCGATGGAGAAGAAGCTTCAAAAGATTCTGCATTTTCAGCTAGTTTTTCCT
ATGAGTTTTCTAGA 
 
CPn1018 
AAGCTTCTGGTTTACAAGTGGAAAATGATATATTTGCTGTAGAGGATGTCGTATT
TCAATTACCAAAAGAACTCCGTTGTTCTTAGGTCTTTAGGCTTACTTGCCAAGTCT
AGA 
 
CPn0769 
AAGCTTATAGAGGTCCTCACGCAATTAGATTAATGAAAAAGTCCTTAATTATAGT
AGAATCACCTGCAAAAATTAAAACGCTACAAAAATTATTAGGGAGTGAATTTGTT
TTTGCCTCTAGA 
 
MalQ 
AAGCTTGTAATAGTTTTGTTTTTATGAATGTTTTAAAATACACAAAACACTCACCC
TCAGCACATGCTTGGAAACTTATAGGAACCTCTCCTAAACACGGGATTTATCTCC
CATCTAGA 
 
GlgA 
AAGCTTGTAATAGTTTTGTTTTTATGAGAATCGTACAAGTCGCTGTAGAATTCACT
CCAATCGTTAAAGTAGGCGGTCTAGGCGATGCTGTAGCTAGTCTATCTAAGGAGT
TATCTAGA 
 
GlgB 
AAGCTTGTAATAGTTTTGTTTTTAGTGTTGATAAACTGATCCATCCTTGGGATCTT
GATCTGCTCGTCTCAGGACGACAGAAAGATCCCCATAAACTCTTAGGGATCCTTG
CTTCTAGA 
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GlgC 
AAGCTTGTAATAGTTTTGTTTTTATGATAGAAAACGATTTTCCGGAGGCCTCAAAT
TTTGAGAGCTCTCATTTTTATCGAGATAAGGTTGGAGTAATTATCTTGTGTGGAGG
GTCTAGA 
 
GlgP 
AAGCTTGTAATAGTTTTGTTTTTATGGAAGATTTTTCGAGTTTTGATAAGAACAAA
GTCAGTGTTGACTCTATGAAACGGGCGATTTTAGATCGTCTGTATTTAAGTGTTGT
ATCTAGA 
 
GlgX 
AAGCTTGTAATAGTTTTGTTTTTATGGAAAAAGTTTCTTCTTATCCCTCAGTTCCTT
TACCTCTTGGGGCTTCTAAAATTTCCCCAAACCGCTATCGATTTGCTTTATATGCT
TCTAGA 
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7.2 Details of phylogenetic trees  
All trees are cropped for lack of space. Bootstrap cut-off: 50%. 
 
GlgA – Glycogen Synthase 
 
 
 
GlgB – Branching Enzyme 
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GlgC – ADP-Glucose pyrophosphorylase 
 
 
 
 
GlgX – Debranching Enzyme 
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GlgP – Glycogen Phosphorylase 
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 MalQ –  -1,4 Glucanotransferase 
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Zusammenfassung 
 
Chlamydiae sind obligat intrazelluläre Parasiten, welche ein breites Spektrum von 
Organismen wie Tiere, Insekten oder Amöben infizieren. Diese Gram-negativen Bakterien 
stellen eine weltweit vermeidbare Hauptursache für Blindheit und Unfruchtbarkeit in 
Menschen dar. Infizieren Chlamydiae eine eukaryotische Wirtszelle, so bilden sie ein 
spezielles Kompartiment aus, die Inklusion, in der sie sich vermehren und von der 
infektiösen, metabolisch inaktiven Form in die nicht-infektiöse, aber metabolisch aktive Form 
konvertieren. Beide Formen besitzen ein Typ III Sekretionssystem, mit dem sie potentiell 
toxische Effektorproteine in die Wirtszelle translozieren. 
Aufgrund des intrazellulären Lebensstils von Chlamydiae konnten bis heute noch keine 
Strategien entwickelt werden, sie genetisch zu manipulieren. Dies wirkt sich erschwerend auf 
die Identifikation neuer Effektorproteine aus. Eine zusätzliche Komplikation wird dadurch 
hervorgerufen, dass die molekulare Erkennung von Effektoren durch die Typ III 
Sekretionsmaschinerie noch ungeklärt ist. Dennoch wird die Hypothese, dass sich dieses 
Erkennungssignal in den ersten 20 Aminosäuren des N-Terminus befinde, von einigen 
Versuchen gestützt.  
Um neue Typ III sezernierte Proteine zu identifizieren, bedienten wir uns des schon 
veröffentlichten Versuchsansatzes, bei dem der Sekretionstest von Chlamydiae-Effektoren in 
einem heterologen Typ III Sekretionssystem von Shigella flexneri durchgeführt wurde. 
Hierfür erstellten wir Chimären, welche aus den ersten 20 Aminosäuren des N-Terminus des 
potentiellen Effektors und einem Reporter-Protein, der Calmodulin-abhängigen 
Adenylatcyclase (Cya) von Bordetella pertussis, bestanden. Diese Chimären exprimierten wir 
in unterschiedlichen Shigella flexneri-Stämmen. Durch den Gebrauch eines Antikörpers 
gegen Cya konnten wir die Chimären lokalisieren und ihre Sekretionseigenschaften 
bestimmen. 
Um eine Liste von zu testenden Kandidaten zu erstellen machten wir uns das Wissen zunutze, 
dass viele Effektoren Signaturen von Proteindomänen, die typischerweise in Eukaryoten 
gefunden werden, besitzen. Durch die Software „Effective“ erhielten wir vorausberechnete 
Listen von Proteinen aus den Proteomen von Chlamydia trachomatis, Chlamydophila 
pneumoniae und Chlamydophila caviae, welche eine Anreicherung dieser eukaryotisch-
ähnlichen Domänen besitzen. Anhand des oben erwähnten heterologen Sekretionstests 
konnten wir zeigen, dass 17/25 getesteten Kandidaten tatsächlich durch ein Typ III 
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Sekretionssystem sezerniert wurden. Die Software „Effective“ stellt daher eine sehr nützliche 
Methode dar. Jedoch kann sie nur als Zusatz verwendet werden, da wir auch andere Proteine 
positiv getestet haben, die nicht von dem Effective-Programm aufgelistet wurden. 
Zusätzlich dazu unterzogen wir eine Auswahl an Proteinen der Umweltchlamydien, welche 
eine Rolle im Glykogenmetabolismus spielen, ebenfalls dem Sekretionstest. Diese Auswahl 
wurde hinsichtlich der Funktionen dieser Enzyme getroffen, welche diese bei einer 
Stabilisierung der Endosymbiosebildung zwischen einem Cyanobiont und einem 
heterotrophen Organismus erfüllt haben könnten. Wir zeigten, dass fast alle diese Enzyme 
sezerniert wurden, und dass einige von ihnen am engsten mit Pflanzenhomologen verwandt 
zu sein scheinen. Dies unterstützt die Hypothese, dass Chlamydiae eine unabdingbare Rolle in 
der frühen Entstehungsgeschichte der heutigen Pflanze einnahm.  
Weiters untersuchten wir Homologe dieser Enzyme in C. trachomatis und C. pneumoniae auf 
unterschiedliche Sekretionseigenschaften, da es bekannt ist, dass nur C. trachomatis 
Glykogen akkumuliert. Wir zeigten Unterschiede auf und gaben Anregungen für weitere 
Überlegungen. 
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